rfhg_200979.1

Basic information about the TSS

---

TSS ID: rfhg_200979.1 Species: human Chr: chr18		Start: 3449530 End: 3449584 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2975916,EH38E1895936)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Transcript_name: ENST00000551557.1 Distance: 0 GeneID: 7050 HGNC/MGI_ID: HGNC:11776 UniProt_ID:

Gene_name: TGIF1 Gene_symbol: TGIF1 Gene_synonyms: Gene_source: HGNC:11776

TATA-Box annotation

---

Distance to TSS:	-94
Nearest PromoterID:	NM_173209
Entrez ID:	7050
Nearest Unigene:	Hs.373550
Nearest Refseq:	NM_003244
Nearest Ensembl:	ENSG00000177426
Gene Name:	TGIF1
Gene Alias:	HPE4|TGIF
Gene Description:	TGFB induced factor homeobox 1
Gene Type:	protein-coding
CpG%:	0.074074
GC%:	0.727273
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TGIF1 p2@TGIF1 p3@TGIF1 p4@TGIF1 p5@TGIF1 p6@TGIF1 p7@TGIF1 p8@TGIF1 p9@TGIF1 p10@TGIF1
Sample		p1@TGIF1	p2@TGIF1	p3@TGIF1	p4@TGIF1	p5@TGIF1	p6@TGIF1	p7@TGIF1	p8@TGIF1	p9@TGIF1	p10@TGIF1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	17.34	0.58	0.00	0.39	2.53	0.58	0.00	0.97	0.39	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	18.21	0.20	0.20	1.01	1.62	0.81	0.20	0.20	0.00	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	21.99	0.58	0.00	1.16	1.54	0.19	0.19	0.19	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	14.76	0.21	0.21	1.04	1.25	0.42	0.00	0.42	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	16.87	0.22	0.22	0.90	1.57	0.45	0.00	0.90	0.22	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	15.31	0.19	0.78	0.19	2.13	0.19	0.00	0.39	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	12.20	0.00	0.22	0.65	0.65	0.44	0.44	0.87	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	9.45	0.73	0.00	0.73	0.97	0.97	0.48	0.48	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.47	0.43	0.21	0.85	2.56	1.28	0.00	0.21	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	13.91	0.00	0.00	3.48	0.58	0.00	0.58	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	12.94	0.40	0.40	2.02	0.81	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	15.45	0.81	0.41	1.22	1.22	0.00	0.00	0.41	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	27.24	0.81	1.93	1.61	1.13	0.64	0.48	0.32	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	25.86	0.45	2.56	1.20	0.60	0.45	1.50	0.60	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	22.83	0.66	2.42	0.88	0.00	0.44	0.22	0.22	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	32.19	0.25	1.76	1.51	1.26	0.00	0.00	0.50	0.25	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	26.86	0.44	4.37	1.75	0.66	0.44	1.53	0.44	0.00	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	29.95	0.42	3.37	2.53	0.42	0.00	1.27	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	34.12	1.60	2.13	2.67	1.60	0.53	1.07	0.53	0.53	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	30.84	1.05	2.11	1.81	3.31	0.75	0.75	0.60	0.45	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	41.83	0.67	2.94	2.41	2.67	1.34	1.07	0.94	0.40	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	43.50	2.07	1.73	5.01	3.45	0.35	2.24	0.35	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	38.65	1.42	2.59	2.20	2.07	0.65	1.42	0.26	0.65	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	30.82	1.46	1.94	3.64	4.61	0.24	1.70	0.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	36.12	1.55	1.03	4.90	4.64	0.77	2.84	0.52	1.29	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	43.68	2.22	2.53	4.11	2.85	0.32	4.43	0.32	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	32.42	0.55	1.65	3.30	1.65	0.00	4.40	0.55	2.20	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	41.96	2.83	3.77	8.72	1.41	0.47	5.66	0.71	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	37.31	1.78	1.94	5.33	1.62	0.81	4.20	0.16	0.65	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	40.54	2.35	2.53	5.79	2.35	0.54	4.71	1.09	0.36	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	27.42	1.88	2.30	4.19	0.42	0.84	3.77	0.21	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	29.11	1.17	4.10	3.71	0.98	0.59	4.30	0.39	0.59	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	35.87	2.32	3.17	4.64	0.84	1.48	4.43	0.42	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	32.33	2.97	2.64	4.95	0.33	0.66	3.63	0.66	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	28.80	2.62	2.24	5.42	0.37	0.37	4.49	0.75	0.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	26.44	3.83	2.68	4.98	0.96	1.53	4.22	0.77	0.19	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	16.96	1.23	2.66	2.66	1.23	1.02	2.45	0.61	0.61	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	18.94	1.41	1.61	1.81	0.81	0.60	2.42	0.20	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	21.07	1.62	2.43	2.70	0.54	1.62	2.43	0.54	0.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	20.17	0.48	2.16	1.68	0.48	0.48	0.48	0.72	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	21.88	2.12	3.76	1.41	0.24	1.65	0.71	0.47	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	24.74	0.73	2.64	2.34	0.59	0.88	1.02	1.17	0.44	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	18.56	0.21	2.74	2.53	1.27	0.84	1.48	0.42	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	20.63	0.35	2.45	1.75	1.75	1.75	1.57	0.52	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	17.67	0.20	2.01	2.01	1.41	1.20	1.00	0.80	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	19.77	0.00	2.33	2.33	1.16	0.47	0.70	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.95	0.72	1.44	1.92	0.96	0.96	1.44	1.68	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	21.76	0.60	2.98	1.49	0.89	0.60	0.00	0.30	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	21.78	0.96	1.20	3.83	2.15	0.72	1.91	0.72	1.68	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	23.45	0.61	2.22	2.43	1.21	1.01	1.62	0.61	0.20	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	27.67	1.02	2.46	2.46	1.64	0.41	2.05	0.82	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	19.35	1.33	2.89	2.45	1.56	0.44	1.56	1.33	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	0.00	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	14.90	0.35	1.77	1.77	1.06	1.42	1.42	1.42	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	13.59	0.33	1.66	1.33	1.66	1.33	0.99	1.33	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	51.18	3.36	3.36	5.87	1.68	0.00	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	32.15	0.00	3.67	3.67	1.38	0.92	0.00	0.00	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.32	0.00	0.97	0.32	1.62	0.65	0.65	0.32	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	5.46	0.64	2.25	1.61	1.28	0.64	0.96	0.64	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	34.58	0.94	2.51	3.14	1.89	0.31	1.26	0.63	0.94	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	14.10	0.71	2.12	2.82	2.12	0.71	0.00	2.82	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	10.65	0.00	1.12	0.56	1.68	1.12	0.56	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	43.79	0.80	0.00	4.78	2.39	0.80	0.80	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	26.84	0.34	2.04	1.36	1.36	0.00	0.00	0.34	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	7.47	0.97	0.65	1.62	1.95	0.32	0.65	1.30	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	7.10	0.35	1.77	0.71	0.71	0.35	0.35	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	7.90	15.79	7.90	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.29	0.00	0.98	0.00	1.46	0.49	0.49	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	12.40	0.00	2.48	0.00	0.00	1.49	0.00	0.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	13.60	0.00	0.47	0.00	1.41	0.47	0.47	1.88	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	20.53	0.33	1.32	0.99	2.98	0.99	0.33	1.32	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	4.64	0.31	1.24	1.24	0.00	0.93	0.00	0.62	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.64	0.00	0.61	0.31	1.83	0.92	0.00	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	30.73	4.59	3.96	5.07	0.63	2.38	2.06	1.11	1.27	0.16
Adipocyte - breast, donor2	11327-117E4	16.36	1.28	2.73	1.93	0.00	1.76	1.28	0.80	0.32	0.00
Adipocyte - omental, donor1	11473-119C6	39.95	4.83	3.56	6.11	0.76	1.27	2.93	2.04	1.91	0.13
Adipocyte - omental, donor2	11474-119C7	9.72	1.49	4.48	0.75	0.00	0.75	2.24	2.24	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	14.40	3.35	2.34	1.67	0.33	2.01	3.68	1.34	1.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	44.66	3.19	4.47	5.74	1.28	1.28	2.55	0.00	3.83	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	11.00	1.10	2.20	0.00	1.10	0.00	2.20	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	11.74	0.00	2.26	2.26	0.00	2.26	1.81	3.16	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	3.48	1.39	1.04	0.87	0.35	1.56	0.52	0.52	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	32.07	1.76	2.74	1.17	0.78	2.15	0.78	1.17	0.39	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	49.93	1.03	1.80	2.32	1.03	2.06	1.80	0.00	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	22.86	1.12	3.35	1.67	0.00	0.56	1.12	1.12	0.28	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	18.22	0.59	1.18	0.00	0.59	1.76	1.18	0.59	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	3.94	0.48	0.32	0.24	0.00	1.21	0.32	0.80	0.00	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	15.49	0.32	1.29	3.23	0.65	1.61	1.29	0.97	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	9.60	2.13	1.07	0.00	0.00	0.53	2.13	0.53	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	3.34	0.56	1.67	1.11	0.00	0.56	0.00	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	2.91	0.00	1.25	0.83	0.00	0.42	0.42	0.83	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	10.30	0.00	1.00	2.26	0.00	1.26	0.75	0.25	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	8.84	0.33	0.33	0.65	0.33	0.65	0.33	0.98	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	2.74	0.30	0.30	0.61	0.00	0.91	0.30	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	40.00	1.10	0.88	2.21	2.87	0.88	1.10	0.66	0.22	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	25.82	0.36	0.00	1.79	0.36	1.79	0.00	0.00	0.00	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	45.52	0.00	1.20	1.20	1.20	1.20	1.20	1.20	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	59.73	2.34	1.44	0.36	0.36	1.08	0.90	0.72	1.44	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	43.51	0.00	1.67	0.00	1.67	0.00	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	53.83	1.85	0.62	0.41	0.82	0.41	1.03	0.41	1.03	0.00
Anulus Pulposus Cell, donor1	11248-116E6	42.11	1.37	4.46	2.40	0.34	0.92	2.40	0.46	0.46	0.69
Anulus Pulposus Cell, donor2	11463-119B5	29.39	0.73	4.16	0.73	0.24	0.24	1.71	0.73	0.49	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	23.36	0.90	0.45	4.04	0.90	0.45	1.80	0.90	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	29.96	0.43	2.17	6.95	1.30	1.30	2.17	0.87	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	27.82	0.00	4.28	0.00	0.00	0.00	2.14	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	31.39	1.49	1.79	3.59	0.60	1.79	2.09	0.00	0.60	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	43.00	1.26	2.53	3.79	2.53	1.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	23.10	0.66	1.98	3.30	0.00	1.32	3.30	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	29.56	1.95	2.92	2.60	0.32	1.30	2.27	0.65	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	28.16	0.00	0.97	2.43	0.49	0.00	1.94	0.49	1.46	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	25.54	0.59	1.78	1.78	2.97	0.59	1.19	0.00	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	22.22	1.13	1.13	4.52	1.51	0.38	3.01	0.75	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	31.20	2.18	2.18	6.53	2.90	2.90	0.73	1.45	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	20.06	0.00	1.25	2.51	0.00	3.76	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	27.84	1.65	2.80	4.78	0.49	0.82	0.82	0.82	0.16	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	21.84	1.36	1.36	1.36	0.00	2.73	1.36	1.36	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	16.74	0.90	2.41	2.71	1.06	0.75	1.06	0.45	0.00	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	30.00	0.00	0.54	5.36	1.07	1.07	1.07	0.00	0.54	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	28.34	1.13	0.76	4.53	1.32	0.76	1.70	0.38	1.13	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	31.01	0.53	1.34	4.01	1.07	0.80	1.34	1.07	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	28.29	1.95	0.98	3.90	0.00	0.00	0.98	1.95	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	29.36	1.82	2.65	4.48	0.50	0.33	1.49	0.17	0.17	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	25.22	0.00	1.20	2.40	1.20	0.00	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	32.25	0.86	2.92	3.95	0.86	0.86	1.54	0.69	1.03	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00	0.00	0.00	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	30.10	0.49	2.91	2.43	0.49	0.49	1.94	1.46	0.00	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	26.56	1.90	3.04	3.79	1.52	0.38	1.90	0.76	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	25.44	3.63	1.21	1.21	0.00	0.00	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	34.77	0.00	0.57	3.42	2.28	0.00	1.14	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	32.49	0.21	2.14	4.06	1.28	0.64	1.71	0.64	0.21	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	22.71	1.55	2.32	4.65	0.52	0.00	1.55	1.03	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	26.28	0.94	3.28	3.28	0.47	0.94	1.88	0.00	0.94	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	29.90	1.29	0.96	5.47	0.32	0.32	1.61	1.29	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	18.55	1.43	2.14	3.57	0.71	2.14	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	23.40	0.00	0.58	4.09	1.75	0.58	2.34	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	29.51	0.30	1.81	2.41	0.90	0.30	0.90	0.30	0.90	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	17.82	1.19	3.56	3.56	1.19	1.19	3.56	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	35.09	0.51	3.05	4.07	0.51	0.00	1.53	1.02	0.00	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	31.33	0.76	1.53	4.33	1.27	0.25	3.06	0.76	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	24.14	0.64	1.27	3.18	0.00	0.00	3.18	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	25.89	1.29	1.73	4.32	1.29	0.86	1.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	21.38	1.27	2.54	3.81	0.64	0.85	1.27	0.42	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	19.43	0.00	1.16	2.03	1.16	0.29	1.45	0.00	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	32.12	0.94	0.94	1.89	2.83	0.00	0.94	0.94	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	23.39	0.85	1.70	4.41	1.19	0.85	2.54	0.17	0.17	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	0.00	0.00	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	0.00	0.00	2.11	0.00	0.00	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	30.88	1.50	1.93	5.36	1.07	1.50	3.65	0.64	0.43	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	22.26	0.60	2.41	3.01	1.20	0.00	1.80	1.80	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	29.16	1.46	2.92	4.37	0.00	0.73	2.19	0.73	0.00	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	33.56	1.38	2.07	3.91	0.92	0.69	1.61	0.46	0.46	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	5.10	0.00	10.20	0.00	0.00	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	25.17	1.53	2.03	3.05	0.76	0.51	0.76	2.29	0.51	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	42.11	1.86	2.06	5.99	1.03	1.86	2.06	0.41	0.41	1.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	30.91	1.53	1.53	3.06	1.22	0.61	0.61	1.22	0.31	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	40.63	2.87	1.91	5.26	2.87	0.96	4.30	0.48	0.96	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	40.58	1.33	3.55	4.88	1.77	1.11	1.77	0.89	0.89	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	3.05	1.53	4.58	1.53	3.05	3.05	3.05	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	47.63	3.88	3.32	4.98	1.11	2.77	2.77	1.11	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	32.04	1.32	2.12	4.50	0.53	0.26	3.44	0.79	1.06	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	29.80	1.82	3.63	5.09	1.09	1.09	1.45	0.73	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	31.20	0.86	0.98	1.84	0.25	0.49	0.86	0.25	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	21.91	0.68	1.54	1.37	0.34	0.51	0.86	0.51	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	21.18	0.63	0.84	2.10	0.63	0.42	0.84	0.42	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	33.12	2.79	1.05	4.53	0.35	0.00	2.44	0.35	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	29.44	1.62	3.07	4.37	0.65	0.00	1.62	0.32	0.65	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	31.92	1.04	2.24	3.73	1.19	0.89	1.79	0.15	0.30	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	0.69	0.00	0.00	0.00	0.00	0.00	0.00	0.11	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	0.11	0.00	0.00	0.00	0.00	0.11	0.00	0.11	0.00	0.00
Basophils, donor1	12241-129G9	40.01	1.05	0.26	1.31	29.55	13.60	0.26	4.71	0.52	1.83
Basophils, donor2	12242-129H1	37.52	1.80	0.00	1.08	18.40	10.10	0.00	5.05	0.36	4.33
Basophils, donor3	12243-129H2	36.75	1.62	0.88	1.32	32.93	11.02	0.44	4.70	0.88	5.59
Bronchial Epithelial Cell, donor1	11511-119G8	32.34	2.80	0.65	1.08	0.00	0.00	0.65	0.22	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	24.69	2.29	0.91	1.37	0.46	0.00	0.91	0.00	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	21.97	2.51	1.26	1.26	5.02	0.00	1.26	0.00	1.26	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	24.95	2.08	0.83	1.04	1.66	0.21	1.25	0.21	0.00	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	80.60	3.45	0.92	1.84	4.15	0.46	1.38	0.46	0.92	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	26.63	5.76	1.80	0.72	1.08	0.18	1.44	0.00	1.44	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.21	0.00	0.00	0.00	0.21	0.00	0.10	0.00	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.47	0.47	0.00	0.23	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	16.95	0.32	0.00	0.00	3.52	5.44	0.00	2.88	0.32	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	20.85	1.13	0.56	0.56	26.49	16.91	0.56	7.33	0.00	2.82
CD14+ Monocytes, donor2	11305-117B9	24.31	1.11	1.30	0.93	31.18	12.44	0.56	6.31	0.93	8.17
CD14+ Monocytes, donor3	11381-118B4	14.93	0.88	1.54	0.66	41.93	8.56	0.00	5.05	1.32	8.78
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	24.06	0.57	3.40	0.28	0.85	5.09	0.85	4.53	1.98	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	26.16	1.52	1.52	0.76	0.00	7.96	0.76	1.52	0.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	21.37	0.99	0.99	1.31	0.33	3.94	0.33	2.63	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	110.44	31.08	3.47	2.75	13.88	11.13	6.94	11.42	7.52	2.89
CD14+ monocytes - mock treated, donor2	11873-125C1	138.20	24.44	2.41	2.11	8.75	10.26	4.83	11.77	11.16	2.72
CD14+ monocytes - mock treated, donor3	11883-125D2	103.52	31.27	2.37	2.37	9.95	11.61	8.53	10.66	13.03	5.45
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	82.19	20.42	2.01	3.01	12.55	14.73	4.85	12.55	8.37	4.02
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	95.78	25.12	2.21	2.48	13.25	12.70	3.86	13.25	10.21	2.48
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	123.22	28.76	3.47	4.46	24.05	14.38	6.94	17.85	12.40	10.66
CD14+ monocytes - treated with BCG, donor1	11860-125A6	61.68	27.61	1.76	1.17	15.08	14.29	9.40	16.84	12.53	5.87
CD14+ monocytes - treated with BCG, donor2	11870-125B7	62.50	30.62	1.42	1.42	14.42	13.89	8.01	15.49	10.50	2.67
CD14+ monocytes - treated with BCG, donor3	11880-125C8	102.50	45.27	3.05	1.74	22.63	15.45	12.84	19.59	16.54	7.83
CD14+ monocytes - treated with Candida, donor1	11868-125B5	93.18	17.33	6.09	3.51	32.31	24.82	7.02	12.88	9.13	22.48
CD14+ monocytes - treated with Candida, donor2	11878-125C6	82.37	15.84	2.11	2.11	41.19	27.99	4.22	19.54	9.50	12.14
CD14+ monocytes - treated with Candida, donor3	11888-125D7	123.14	28.84	1.11	6.66	35.50	26.62	4.44	18.86	5.55	19.97
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	116.47	31.68	3.42	3.57	12.20	16.96	7.88	13.83	11.45	6.25
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	117.93	25.94	1.80	1.80	11.97	10.98	4.59	11.37	9.58	3.39
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	126.59	36.02	3.33	2.50	13.12	11.66	10.41	16.03	14.78	5.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	112.33	34.78	5.95	5.03	31.11	21.28	11.44	19.90	11.67	31.34
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	105.86	35.51	2.71	2.26	23.75	10.18	5.43	13.35	11.08	7.24
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	111.30	34.92	4.36	6.11	24.88	12.66	10.91	16.59	10.04	33.17
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	55.68	31.20	1.08	0.81	8.88	6.99	6.72	10.22	11.03	3.50
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	87.06	39.95	1.40	2.79	14.31	12.04	7.33	15.35	12.91	5.41
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	82.90	37.87	0.84	1.68	12.20	10.52	10.10	13.05	12.20	6.73
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	58.05	22.23	1.47	2.02	16.35	19.29	5.33	19.84	8.45	8.63
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	51.43	16.20	0.35	2.82	14.09	15.85	2.82	13.03	8.10	2.82
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	53.96	17.11	0.44	1.32	10.53	14.04	4.39	11.85	6.14	10.09
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	65.04	26.33	1.22	0.70	16.04	17.09	8.89	18.13	11.16	8.89
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	78.42	37.91	0.37	1.12	15.98	19.33	7.06	20.81	10.04	4.83
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	123.51	46.56	1.51	1.29	28.45	21.77	15.95	25.43	15.52	8.84
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	44.22	7.78	2.05	1.64	7.37	13.92	4.50	12.69	4.91	9.01
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	63.74	13.91	2.32	1.85	12.98	11.13	0.93	17.62	6.26	6.03
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	57.77	20.42	1.86	0.93	12.53	14.62	4.64	17.86	9.74	9.98
CD14+CD16+ Monocytes, donor1	11789-124B7	9.15	0.22	0.65	0.44	6.97	5.01	0.00	2.62	0.22	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	10.16	0.00	0.46	0.46	6.70	6.01	0.00	3.23	1.15	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	13.43	0.22	1.08	0.43	11.91	5.85	0.00	3.90	1.08	2.60
CD14+CD16- Monocytes, donor1	11788-124B6	35.97	0.62	1.71	0.93	12.77	11.37	0.78	9.50	1.09	1.87
CD14+CD16- Monocytes, donor2	11799-124C8	35.98	0.00	0.52	1.22	13.62	9.43	0.35	5.06	0.17	1.40
CD14+CD16- Monocytes, donor3	11910-125G2	29.65	0.22	0.45	0.45	11.15	7.36	0.00	3.57	0.67	1.34
CD14-CD16+ Monocytes, donor1	11790-124B8	4.85	0.51	0.00	0.00	4.08	3.83	0.00	2.81	0.51	3.83
CD14-CD16+ Monocytes, donor2	11800-124C9	1.76	0.44	0.00	0.00	1.10	1.76	0.00	1.10	0.44	1.76
CD14-CD16+ Monocytes, donor3	11911-125G3	1.89	0.21	0.21	0.00	3.79	2.53	0.00	1.26	0.42	2.53
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	22.36	2.03	0.00	0.00	0.00	0.00	0.00	2.03	2.03	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	34.58	1.36	0.00	0.00	0.00	2.71	0.00	2.03	1.36	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	19.68	2.07	0.00	0.00	2.07	3.11	0.00	1.04	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	22.39	2.13	0.00	0.00	1.60	3.20	0.53	0.53	4.26	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	28.41	3.75	0.54	0.00	1.61	4.29	0.54	1.07	1.07	3.22
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	22.46	4.21	0.00	0.00	0.00	1.40	0.70	2.11	3.51	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	32.16	4.71	0.00	0.00	0.00	4.71	0.00	1.57	0.00	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	30.32	7.91	0.00	0.00	1.32	2.64	0.00	0.00	3.95	5.27
CD19+ B Cells, donor1	11544-120B5	30.41	0.00	0.00	0.00	18.08	4.11	0.00	0.00	3.29	8.22
CD19+ B Cells, donor2	11624-122B4	44.98	1.45	0.00	0.00	9.43	5.80	0.00	1.45	0.00	5.08
CD19+ B Cells, donor3	11705-123B4	57.55	1.01	0.00	0.00	13.13	5.05	1.01	1.51	1.01	13.13
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	20.20	2.83	0.40	0.81	2.42	0.81	1.21	0.40	2.02	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	23.97	2.40	0.00	0.00	5.59	0.80	0.00	0.80	2.00	1.60
CD34+ Progenitors, donor1	11545-120B6	28.11	2.01	0.00	0.00	2.01	5.02	1.00	3.01	0.00	9.04
CD34+ Progenitors, donor2	11625-122B5	46.63	1.12	0.00	0.56	4.49	10.11	0.56	5.06	1.69	4.49
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	28.56	0.75	0.38	0.38	1.88	4.88	0.00	3.38	0.00	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	30.21	0.90	0.23	1.13	2.03	5.86	0.00	3.61	0.90	0.90
CD4+ T Cells, donor1	11225-116C1	36.42	0.00	0.00	0.00	3.93	0.36	0.36	0.71	0.36	6.07
CD4+ T Cells, donor2	11306-117C1	42.25	2.45	0.61	0.00	5.51	3.06	0.00	0.00	1.84	15.92
CD4+ T Cells, donor3	11382-118B5	41.78	1.22	0.00	0.61	11.59	2.13	0.91	3.05	0.61	14.64
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	3.32	0.26	0.00	0.00	0.00	0.51	0.00	0.00	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	3.14	0.00	0.00	0.00	0.00	0.22	0.00	0.22	0.45	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	6.90	0.29	0.00	0.00	0.00	0.29	0.00	0.57	0.57	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	158.82	5.22	0.00	0.47	1.90	2.37	1.90	2.37	4.27	27.50
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	158.72	7.73	0.70	0.00	0.70	3.51	0.70	2.81	4.21	9.13
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	105.48	0.00	0.00	0.00	0.00	3.30	0.00	0.00	0.00	36.26
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	9.68	0.87	0.00	0.00	0.14	1.16	0.00	0.14	1.16	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	3.22	0.00	0.00	0.00	0.17	0.00	0.00	0.00	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	1.29	0.16	0.00	0.00	0.32	0.48	0.00	0.16	0.32	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	52.90	1.79	0.45	0.00	1.34	2.24	0.00	0.00	1.34	6.72
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	43.32	1.05	1.05	0.35	0.70	1.05	0.35	0.70	2.45	4.19
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	29.48	1.76	0.00	0.44	0.44	0.88	0.00	0.88	0.88	3.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	8.01	0.42	0.00	0.00	1.26	1.69	0.00	0.42	0.00	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	4.57	0.21	0.21	0.00	0.83	0.62	0.00	0.21	0.21	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	4.34	0.33	0.00	0.00	1.34	1.00	0.00	0.33	0.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	45.41	1.09	0.00	0.82	2.18	0.54	0.54	0.82	3.54	6.25
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	42.34	2.14	0.54	0.00	2.14	0.54	0.54	0.00	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	37.66	0.00	0.00	0.00	8.97	1.79	0.00	0.00	0.00	8.97
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	9.83	0.74	0.37	0.00	0.00	0.93	0.19	0.37	0.56	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	12.13	0.65	0.22	0.22	0.22	1.95	0.22	0.43	0.43	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	15.13	2.10	0.21	0.00	0.84	1.68	0.00	0.63	1.68	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	55.62	2.53	0.00	0.00	4.55	3.54	0.51	3.54	1.52	10.62
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	64.12	3.03	0.87	0.43	6.07	2.60	0.87	3.90	2.60	2.17
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	67.55	1.31	0.87	0.00	3.05	1.74	0.00	0.87	2.18	3.49
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	72.25	6.43	0.99	0.00	0.00	3.46	0.00	0.49	8.41	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	66.47	6.46	0.00	0.00	0.00	3.69	0.00	1.85	7.39	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	89.33	6.98	0.00	0.00	0.00	8.37	0.00	0.00	5.58	5.58
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	49.85	4.98	0.55	0.00	0.83	2.77	0.00	2.22	1.38	2.22
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	58.89	4.91	0.00	0.00	0.00	2.45	0.25	0.74	2.94	1.47
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	56.98	3.08	0.00	0.00	0.00	3.08	0.00	1.54	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	57.66	5.01	0.36	0.00	0.00	3.22	0.72	2.51	3.58	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	99.72	18.00	1.38	0.00	2.77	5.54	0.00	2.77	5.54	4.15
CD8+ T Cells, donor1	11226-116C2	31.10	1.96	0.33	0.00	11.13	3.27	0.00	0.98	2.29	12.44
CD8+ T Cells, donor2	11307-117C2	45.05	1.88	0.00	0.38	9.01	6.01	0.00	1.50	1.50	16.14
CD8+ T Cells, donor3	11383-118B6	30.05	1.01	0.00	0.00	11.87	4.04	0.00	2.02	1.77	21.21
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	7.57	0.69	0.00	0.00	0.23	0.69	0.00	0.92	0.92	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	6.95	0.24	0.00	0.24	0.72	1.68	0.00	0.00	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	7.11	0.27	0.00	0.00	0.55	0.55	0.00	0.27	0.00	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	6.30	0.60	0.00	0.30	0.30	2.40	0.00	0.30	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	13.68	0.72	0.00	0.48	0.00	0.72	0.48	0.48	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.91	0.23	0.00	0.23	0.00	1.14	0.23	1.59	0.45	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	9.56	0.22	0.00	0.22	0.65	1.30	0.65	0.87	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	11.32	0.79	0.00	1.05	0.26	1.32	0.26	1.05	1.05	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	11.73	0.23	0.00	0.23	0.00	0.23	0.47	0.47	0.23	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	9.06	0.60	0.00	0.00	0.30	1.21	0.30	0.60	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	10.17	0.58	0.29	0.29	0.00	0.58	0.58	0.87	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	9.33	0.80	0.00	0.27	0.27	1.60	0.00	1.33	0.80	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	32.39	1.31	0.44	0.88	1.31	2.63	1.75	1.75	1.31	3.50
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	29.60	1.82	0.00	1.37	0.91	1.37	0.91	1.82	0.91	6.83
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	19.39	1.49	0.75	0.00	2.98	1.49	0.00	0.75	0.75	3.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	15.85	1.08	0.36	0.36	0.36	1.44	0.36	0.36	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	14.96	0.58	0.00	1.15	1.44	1.73	0.58	1.73	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	9.66	0.24	0.24	0.94	0.00	1.65	0.71	0.71	0.47	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	12.36	0.63	0.00	0.32	0.00	1.90	0.32	1.58	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	10.76	0.31	0.31	0.31	0.00	2.15	0.31	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	11.22	0.32	0.00	0.64	0.96	1.60	0.32	0.64	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	10.33	0.76	0.00	0.00	0.38	2.68	0.76	0.76	0.76	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	11.03	0.39	0.00	0.39	1.18	1.58	0.39	1.18	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4.54	0.00	0.00	0.00	0.76	3.03	0.00	0.76	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	51.39	0.80	0.00	4.01	0.80	3.21	0.00	1.61	0.00	4.82
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	50.36	1.40	0.00	4.20	4.20	6.29	0.00	2.10	0.00	4.20
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	57.10	1.00	1.00	3.01	5.01	5.01	0.00	1.00	1.00	3.01
Cardiac Myocyte, donor1	11525-119I4	38.38	0.00	1.83	3.66	1.83	0.00	3.66	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	26.68	0.00	2.96	2.96	0.00	1.48	0.99	0.00	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	40.94	2.00	2.42	8.10	0.53	0.84	2.10	0.53	0.63	0.00
Chondrocyte - de diff, donor1	11261-116G1	21.84	2.77	4.51	2.77	1.39	2.43	0.35	0.35	1.73	0.69
Chondrocyte - de diff, donor2	11338-117F6	25.59	2.84	1.78	1.07	0.00	0.71	1.42	0.71	0.00	1.07
Chondrocyte - de diff, donor3	11410-118E6	28.33	1.59	5.35	2.73	0.57	1.59	1.48	1.14	0.68	0.91
Chondrocyte - re diff, donor2	11339-117F7	46.55	1.79	0.00	0.90	0.00	1.79	0.90	1.79	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	33.16	4.04	3.24	2.83	1.62	1.62	2.43	1.62	0.81	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	48.89	0.57	3.79	3.90	0.46	0.23	3.44	0.23	0.46	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	40.19	0.86	4.06	0.64	0.43	0.00	1.28	0.00	0.43	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	42.04	1.24	2.92	1.68	0.88	0.09	2.12	0.27	0.18	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	24.21	1.10	3.12	1.28	0.64	0.83	1.01	0.37	0.46	0.73
Corneal Epithelial Cells, donor1	11526-119I5	55.11	5.27	1.54	1.10	0.66	0.44	1.76	0.00	1.54	0.22
Corneal Epithelial Cells, donor2	11606-120I4	34.13	4.55	1.14	0.00	1.14	0.00	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	39.62	4.09	0.77	1.53	0.26	0.00	1.28	0.00	1.53	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	16.67	1.65	1.16	0.17	0.33	1.49	0.33	0.99	0.66	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	18.29	1.89	1.58	0.63	0.00	1.89	0.32	4.10	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	3.45	0.00	3.45	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	10.91	0.54	0.43	0.32	0.11	1.62	0.43	1.51	0.43	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	3.76	0.00	0.00	0.00	2.39	1.71	0.00	1.02	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	4.57	0.00	0.00	0.00	1.96	0.00	0.00	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1.45	0.48	0.48	0.00	1.45	0.48	0.00	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	39.52	0.83	1.67	4.17	2.67	0.17	0.67	0.00	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	31.69	0.00	1.17	1.17	2.93	0.59	0.59	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	37.05	2.55	1.98	2.55	0.00	0.57	0.85	0.28	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	23.98	0.00	1.18	1.57	0.79	0.00	0.00	0.39	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	20.07	1.75	2.04	2.33	0.87	0.29	0.87	0.00	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	31.76	0.94	1.41	4.24	1.18	0.00	0.71	0.24	0.24	0.47
Endothelial Cells - Artery, donor3	11413-118E9	28.58	0.53	2.10	2.28	1.58	0.35	0.88	0.00	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	16.85	0.44	1.99	1.11	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	10.35	1.52	2.13	0.91	0.00	0.00	0.00	0.30	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	23.40	1.13	0.56	3.10	0.56	0.00	0.00	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	43.08	0.30	1.19	2.97	0.30	0.30	0.89	0.00	0.89	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	24.99	1.04	0.52	0.00	0.52	0.00	0.00	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	44.66	1.28	2.41	3.40	0.43	0.00	0.71	0.28	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	29.61	2.00	2.40	2.80	2.00	0.40	0.80	0.40	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	37.21	1.05	1.05	2.62	1.57	0.52	2.62	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	27.33	0.99	2.73	4.35	0.62	0.12	0.50	0.12	0.12	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	18.90	0.22	1.52	1.09	0.43	0.00	0.65	0.00	1.30	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	16.98	0.85	1.59	1.71	0.85	0.12	0.24	0.00	0.00	0.12
Endothelial Cells - Vein, donor1	11267-116G7	35.26	0.00	2.28	1.14	6.83	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	37.72	0.70	0.70	3.49	1.40	0.00	0.00	0.70	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	30.46	1.26	1.26	4.08	2.51	0.31	0.63	0.31	0.16	0.31
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	108.92	1.65	3.30	0.00	36.31	18.15	0.00	3.30	4.95	8.25
Eosinophils, donor3	12246-129H5	53.50	3.57	0.00	0.00	24.97	14.27	3.57	10.70	3.57	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	32.74	2.69	1.95	1.22	0.24	0.24	0.73	0.00	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	47.84	2.08	2.08	0.00	0.00	0.00	4.16	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	26.68	0.82	0.82	2.46	0.41	2.05	2.05	1.23	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.23	0.66	1.97	2.19	0.33	0.66	1.53	0.00	0.33	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	26.98	2.93	2.71	2.38	0.54	0.76	3.47	0.65	0.33	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	30.32	0.85	1.94	4.12	0.85	0.49	2.06	0.85	0.36	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	34.39	1.50	10.78	5.32	5.19	2.32	1.50	0.68	0.96	2.73
Fibroblast - Aortic Adventitial, donor2	11326-117E3	26.37	2.43	2.32	2.32	0.53	0.74	2.95	0.95	0.21	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	39.52	1.84	5.01	3.69	4.48	1.05	2.90	0.26	0.79	1.58
Fibroblast - Aortic Adventitial, donor3	11401-118D6	29.90	1.99	1.99	2.99	0.33	0.66	1.66	1.00	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	24.04	0.45	0.45	3.18	0.45	0.00	0.45	0.00	1.81	0.00
Fibroblast - Cardiac, donor2	11345-117G4	29.56	0.00	1.52	2.27	3.03	0.76	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	20.82	0.79	0.95	0.95	0.79	0.95	2.37	0.79	0.32	0.16
Fibroblast - Cardiac, donor4	11452-119A3	19.10	1.52	3.94	1.82	0.00	0.30	0.91	0.00	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	27.67	0.89	1.78	2.16	0.13	0.51	1.27	0.76	0.00	0.13
Fibroblast - Cardiac, donor6	11460-119B2	16.07	0.76	1.67	3.03	0.45	0.15	0.76	0.15	0.00	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	23.98	0.67	1.34	2.28	0.13	0.54	0.54	0.00	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	11.22	0.00	0.86	0.43	0.43	0.00	0.43	0.00	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	27.83	0.00	0.00	0.00	1.46	0.00	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	107.48	3.69	5.30	4.38	1.38	1.61	1.38	2.08	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	29.68	2.20	6.28	1.87	0.68	1.53	1.19	1.19	0.51	0.51
Fibroblast - Dermal, donor1	11269-116G9	24.89	0.23	3.76	2.82	0.47	0.94	1.41	0.23	1.17	0.23
Fibroblast - Dermal, donor2	11346-117G5	38.68	1.89	1.42	1.42	0.47	0.94	1.42	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	31.91	1.21	4.23	1.81	1.33	1.33	2.78	0.36	0.36	0.36
Fibroblast - Dermal, donor4	11450-119A1	28.37	0.45	1.58	1.36	1.36	1.58	0.79	0.57	0.11	0.68
Fibroblast - Dermal, donor5	11454-119A5	23.03	0.70	1.74	2.09	0.87	1.05	0.52	1.57	0.17	0.00
Fibroblast - Dermal, donor6	11458-119A9	21.60	0.65	2.27	0.97	1.62	1.46	0.81	1.46	0.32	0.00
Fibroblast - Gingival, donor1	11237-116D4	20.41	1.04	4.37	1.46	0.62	0.83	2.08	1.46	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	23.84	1.31	4.19	1.83	0.00	0.00	2.62	0.00	0.26	0.79
Fibroblast - Gingival, donor2	11318-117D4	30.57	0.79	2.77	1.19	0.40	0.79	0.66	1.19	0.00	0.26
Fibroblast - Gingival, donor3	11394-118C8	38.29	1.84	7.73	2.90	0.68	1.45	1.84	1.16	0.68	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	58.18	1.04	7.27	5.19	2.08	3.12	2.08	1.04	4.16	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	59.03	1.76	6.34	2.47	0.35	1.23	3.88	2.47	0.70	1.41
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	26.50	0.31	3.27	1.25	0.31	0.31	1.40	0.47	0.16	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	23.53	0.95	3.52	1.35	0.41	0.41	2.30	0.27	0.68	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	23.29	0.71	1.76	2.82	0.35	1.76	1.41	0.71	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	15.50	0.73	1.46	0.44	0.29	1.02	0.88	0.29	0.58	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	20.45	0.55	2.45	1.64	0.27	0.27	0.41	0.68	0.27	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	25.12	0.66	1.86	1.21	0.99	0.88	0.99	0.55	0.88	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	24.36	3.08	6.31	1.61	0.00	1.91	3.37	1.03	1.17	0.88
Fibroblast - Lung, donor1	11270-116H1	32.62	2.72	4.08	1.36	2.72	0.00	2.72	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	53.72	0.00	1.49	2.98	0.00	1.49	2.98	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	37.35	0.84	4.85	4.43	0.84	1.27	2.32	0.63	0.42	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	49.15	1.67	1.67	4.17	0.83	3.33	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	43.36	1.40	2.80	1.40	2.80	1.40	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	24.63	0.84	1.96	1.96	0.56	1.68	0.56	0.84	0.84	0.28
Fibroblast - Mammary, donor1	11540-120B1	46.28	2.03	1.62	3.65	1.62	2.84	1.22	0.81	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	15.98	0.00	0.00	0.00	0.00	0.00	3.99	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	5.96	0.00	0.00	0.00	11.91	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	27.93	0.97	2.91	1.16	0.39	0.19	0.39	0.58	0.58	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	26.54	0.15	3.49	1.21	0.00	0.30	0.76	0.30	0.15	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	22.34	1.53	5.51	0.92	0.61	0.31	0.92	1.22	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	25.95	0.38	4.20	0.76	0.00	1.91	0.38	0.38	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	30.24	1.35	3.51	0.54	0.27	0.81	1.89	0.81	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	61.58	3.13	5.68	3.13	0.58	2.55	2.67	1.51	0.70	1.28
Fibroblast - Pulmonary Artery, donor1	11250-116E8	34.38	0.77	0.66	4.64	0.66	0.66	1.22	0.44	0.22	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	64.61	2.44	4.47	1.02	1.22	1.22	1.83	1.22	0.61	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	32.07	2.00	0.67	1.34	0.00	0.67	0.67	1.34	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	33.21	2.37	2.37	4.74	2.77	1.19	2.37	0.40	0.79	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	33.54	2.98	3.37	4.17	1.98	1.79	1.19	0.60	1.39	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	36.06	2.66	7.28	0.89	0.36	2.84	1.07	2.66	1.24	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	29.56	1.38	3.74	1.18	0.39	1.58	2.17	1.38	0.39	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	23.47	1.20	4.21	1.50	4.81	1.50	1.50	0.00	0.60	1.81
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	32.28	1.62	4.21	1.19	0.65	1.51	2.48	0.76	0.76	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	37.46	2.28	5.31	3.80	4.81	2.28	0.76	1.77	1.77	2.78
Fibroblast - skin normal, donor1	11553-120C5	23.46	0.98	3.12	0.66	0.66	0.66	0.82	0.49	0.98	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	17.24	1.20	2.81	3.21	8.42	0.20	0.60	0.60	0.60	0.60
Fibroblast - skin normal, donor2	11561-120D4	31.65	1.61	2.31	2.81	0.50	1.61	2.51	0.90	0.90	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	31.13	1.21	5.74	1.51	3.32	1.21	1.51	0.30	0.30	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	24.52	1.82	5.47	1.49	0.17	1.24	1.91	0.75	0.91	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	35.73	4.10	8.03	1.20	0.00	1.03	2.05	1.88	1.54	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.69	1.97	1.31	3.61	5.58	0.66	1.64	0.33	0.66	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	23.12	0.85	1.81	1.07	0.64	1.17	1.07	0.11	0.53	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	30.36	1.69	3.54	1.35	1.01	1.01	1.18	0.17	0.34	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	22.58	2.04	4.23	1.88	0.16	1.10	1.25	0.47	0.94	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	22.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	20.92	1.74	2.61	7.84	0.00	0.00	4.36	0.00	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	54.09	5.37	3.12	2.60	0.69	0.17	2.25	0.87	1.56	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	47.88	6.25	1.56	1.82	0.26	0.78	0.52	0.26	1.82	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	42.16	3.83	2.56	2.81	0.51	0.00	0.00	0.26	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	161.53	1.53	10.72	6.89	2.30	0.00	3.06	0.00	2.30	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	182.49	1.91	10.85	5.74	3.19	1.28	3.83	1.91	1.28	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	132.65	1.71	12.27	2.57	4.56	1.71	0.57	0.29	0.86	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	135.12	1.38	11.58	8.82	11.31	0.55	1.65	0.55	0.83	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	63.47	1.14	6.16	5.02	3.20	0.46	1.14	0.68	0.46	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	92.53	1.59	10.90	1.59	5.94	0.40	0.99	0.99	1.19	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	107.32	2.11	10.31	6.87	11.10	1.06	1.32	0.79	0.53	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	38.16	1.30	4.89	4.24	3.59	0.98	0.98	0.00	0.98	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	116.75	2.65	9.29	2.65	5.75	0.44	0.88	0.88	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	131.57	1.13	6.64	2.40	1.41	0.71	0.85	0.57	0.57	1.55
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	107.50	1.85	5.42	4.06	1.23	0.86	1.11	0.49	0.99	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	99.66	1.88	9.94	3.76	0.81	0.54	1.88	0.00	0.00	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	167.26	3.47	2.11	4.58	5.58	3.47	1.61	2.60	1.61	1.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	175.39	2.91	3.18	5.68	4.71	2.35	0.83	3.32	2.21	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	125.23	2.03	5.69	1.83	2.24	1.83	2.03	1.63	1.02	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	97.66	3.65	3.19	2.28	1.14	1.14	1.14	0.46	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	125.81	1.99	2.87	3.24	2.87	2.24	0.87	1.74	0.75	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	118.03	1.53	2.84	2.62	2.62	5.03	1.09	2.84	0.44	1.31
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	79.19	4.73	4.73	3.55	2.07	0.59	2.07	0.59	1.48	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	94.26	1.43	2.54	2.70	1.59	0.79	0.64	0.64	0.48	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	103.22	2.68	6.48	2.23	0.89	1.34	1.79	0.45	2.01	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	57.67	1.81	2.02	2.82	0.20	0.40	1.01	1.01	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	81.09	2.21	2.54	3.39	1.53	1.02	0.85	2.37	1.87	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	113.94	2.31	3.81	4.52	1.15	1.24	0.89	1.51	1.24	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	65.97	2.08	1.56	2.19	0.83	0.83	1.56	1.35	1.14	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	71.90	2.56	1.02	1.20	0.51	2.05	1.20	0.34	1.02	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	62.85	1.99	1.44	1.22	1.00	0.89	1.11	0.55	1.00	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	79.70	2.75	2.83	3.41	0.92	1.58	1.00	1.00	1.91	1.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	84.74	2.04	2.04	2.25	0.82	1.02	1.23	1.43	1.02	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	60.24	1.24	1.24	1.44	0.62	1.65	1.24	0.41	0.83	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	63.30	1.84	1.73	2.42	1.61	1.27	0.81	0.58	1.61	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	54.53	2.00	1.50	1.33	1.50	1.33	1.17	1.00	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	51.36	1.76	0.88	1.54	0.66	1.32	1.54	0.88	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	60.88	2.34	1.23	1.97	1.35	0.98	0.86	0.98	1.60	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	45.71	1.95	1.95	2.92	1.13	0.65	0.97	1.78	0.81	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	52.60	1.28	1.28	2.25	0.64	1.60	2.25	0.32	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	49.65	3.22	1.80	1.33	0.66	1.33	1.42	1.33	0.76	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	36.86	2.37	0.63	0.79	0.95	1.11	0.63	1.74	0.79	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	49.87	2.74	0.61	2.43	0.61	1.22	1.22	1.22	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	56.14	2.51	0.73	2.40	0.73	1.15	1.57	1.78	0.84	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	39.08	1.76	0.88	0.00	1.32	0.66	0.88	0.66	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	42.08	2.24	2.24	1.40	1.40	0.84	1.40	1.40	1.40	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	41.39	2.50	0.65	1.94	0.83	0.93	0.93	1.39	0.65	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	27.28	1.87	1.60	1.34	1.60	0.53	0.53	2.41	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	52.33	3.67	0.77	2.91	0.61	0.61	1.84	2.30	1.99	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	49.35	2.85	1.04	1.94	0.52	1.42	1.30	1.17	1.17	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	27.11	1.63	1.36	0.27	0.81	1.36	0.00	1.08	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	50.88	2.77	2.40	2.03	0.74	1.47	2.03	1.66	2.40	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	42.55	2.85	0.66	1.97	0.44	1.54	1.32	0.44	1.10	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	32.73	0.00	4.96	0.00	0.00	0.99	0.00	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	46.57	1.06	2.37	1.98	0.79	1.06	2.51	1.06	0.92	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	50.84	2.62	2.82	2.42	1.01	1.41	3.03	0.40	1.61	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	74.21	5.34	4.83	2.54	0.51	2.03	2.29	1.78	1.27	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	149.10	0.40	12.14	3.38	0.80	0.80	1.19	0.40	0.20	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	143.91	2.16	8.94	3.24	1.54	0.77	0.77	0.62	0.46	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	163.87	1.64	10.23	4.71	0.82	1.23	1.23	0.41	0.82	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	134.25	1.25	13.46	3.13	0.63	0.00	1.25	0.31	1.25	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	140.43	0.28	12.43	5.37	0.57	1.13	0.28	0.57	1.13	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	149.43	0.46	18.45	3.23	1.84	0.00	1.38	0.46	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	200.46	2.47	22.27	4.95	2.47	2.47	2.47	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	221.25	1.93	11.60	6.96	2.71	0.77	1.93	0.39	1.93	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	163.66	0.00	11.23	4.81	3.21	0.00	1.60	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	215.61	3.48	17.39	6.96	5.22	0.00	3.48	0.00	0.00	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	202.12	3.58	7.49	3.58	1.95	0.98	0.65	0.00	0.00	2.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	191.49	4.12	8.24	3.29	2.06	1.24	2.47	0.82	0.41	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	83.31	0.00	0.00	3.33	3.33	0.00	0.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	154.65	1.96	6.43	1.40	2.80	0.00	1.12	0.00	0.56	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	175.19	1.96	8.17	5.23	3.60	0.98	0.65	0.65	1.31	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	133.38	0.84	4.19	2.52	3.36	0.84	0.00	0.00	0.84	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	131.36	1.91	4.45	1.91	2.86	0.64	0.32	0.32	1.59	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	133.15	2.04	4.76	2.72	2.72	1.02	1.02	0.34	1.70	3.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	125.29	0.00	2.09	4.18	8.35	0.00	2.09	2.09	0.00	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	142.60	1.15	4.01	1.15	4.58	0.00	1.15	0.57	0.00	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	106.55	1.48	3.26	1.78	4.14	0.00	1.18	0.30	0.00	2.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	52.52	1.69	1.69	0.00	5.08	0.00	0.00	0.00	1.69	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	114.32	1.66	4.56	5.38	2.49	0.41	1.66	0.00	1.24	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	99.19	1.38	5.06	2.53	1.84	0.46	1.61	0.69	0.69	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	73.76	0.00	0.00	0.00	5.27	0.00	0.00	0.00	10.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	89.18	1.15	3.46	1.92	1.15	0.77	1.15	0.00	1.92	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	83.45	1.30	4.89	1.63	1.96	0.98	1.30	0.00	0.98	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	65.55	0.67	3.34	1.34	2.68	0.67	0.00	0.00	0.67	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	149.87	3.47	3.85	1.54	1.93	0.77	1.16	0.77	1.16	4.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	97.22	2.05	1.71	5.48	3.08	0.00	2.05	0.34	1.03	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	69.57	2.48	9.94	2.48	14.91	0.00	0.00	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	99.09	2.36	1.89	0.94	3.30	0.47	1.42	0.94	0.47	5.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	112.25	0.60	2.41	1.81	5.43	2.41	1.81	1.21	1.81	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	103.77	2.03	4.07	1.53	6.61	0.51	0.00	2.03	1.02	3.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	101.70	1.60	0.80	3.19	3.19	0.80	0.80	0.00	1.60	2.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	125.81	1.48	3.95	0.49	3.45	0.99	2.47	0.00	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	95.62	1.18	3.54	2.36	4.72	2.36	1.18	0.00	0.00	7.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	114.36	1.75	1.17	1.17	5.25	0.58	3.50	0.00	1.75	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	122.89	3.51	3.51	3.07	4.39	0.88	1.76	0.00	0.44	4.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	115.29	1.70	5.09	5.09	7.63	0.00	0.00	0.85	0.85	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	84.16	2.39	1.79	1.19	2.98	1.19	1.19	0.60	1.19	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	57.74	1.46	1.46	1.94	2.43	0.00	1.94	0.49	0.49	3.88
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	12.55	0.00	0.00	2.28	0.00	0.00	1.14	1.14	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	15.39	1.25	1.25	0.00	0.00	0.42	0.83	0.83	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	38.23	1.12	3.37	3.37	4.50	0.00	2.25	2.25	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	28.54	1.27	2.54	3.49	2.85	0.63	1.59	0.63	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	7.52	1.25	3.76	0.00	0.42	0.42	0.42	0.00	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	51.99	1.62	1.51	2.67	0.81	1.04	0.81	0.70	1.62	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	64.82	2.53	0.84	2.19	1.01	1.18	0.84	1.69	1.69	1.18
Hep-2 cells mock treated, biol_rep3	11900-125F1	54.60	1.82	1.37	0.91	1.14	1.14	0.46	0.23	1.14	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	58.70	2.19	1.64	1.75	0.77	0.77	0.66	1.31	1.75	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	61.68	1.29	0.86	1.72	0.86	1.93	1.29	0.64	1.07	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	53.82	2.58	1.08	1.94	1.72	1.08	0.86	0.43	1.94	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	22.67	1.99	1.00	1.25	1.00	0.25	0.62	0.37	0.50	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	22.47	1.20	1.03	0.51	0.86	0.17	0.51	0.69	0.51	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	21.14	0.64	1.28	1.28	0.64	0.32	0.64	1.28	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	24.06	1.12	1.12	3.36	1.68	0.56	0.56	0.56	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	31.16	1.30	0.87	2.16	0.87	0.00	0.43	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	34.37	2.64	0.00	0.00	2.64	0.00	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	33.51	2.12	1.41	1.41	0.35	0.35	1.06	0.71	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	30.51	2.18	0.73	1.45	0.00	0.00	2.18	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	27.45	0.52	1.40	3.50	1.40	0.87	1.92	0.87	0.70	0.17
Hepatocyte, donor1	11523-119I2	7.26	1.21	1.21	0.00	0.00	0.00	1.21	0.00	1.21	3.63
Hepatocyte, donor2	11603-120I1	20.47	0.00	1.08	0.00	1.08	0.00	0.00	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	46.02	0.00	1.84	0.61	1.23	0.61	0.61	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00	0.00	1.96	2.61	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	48.59	1.40	8.74	1.05	0.35	0.70	0.35	0.35	0.35	4.72
Iris Pigment Epithelial Cells, donor1	11530-119I9	25.79	0.27	3.16	0.82	0.55	0.41	0.27	0.96	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	38.21	0.00	0.00	3.18	47.76	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	100.13	0.00	6.68	0.00	53.40	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	54.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	0.00	1.38	2.77	31.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	45.05	0.00	0.00	2.50	25.03	5.01	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	0.00	0.00	0.00	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	43.57	0.00	0.00	2.56	23.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	50.28	0.00	4.57	0.00	18.28	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	34.11	0.00	3.25	0.00	21.12	1.62	0.00	4.87	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	26.68	0.00	1.67	0.00	20.01	0.00	0.00	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	0.00	0.00	3.63	29.04	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	45.00	0.00	0.00	0.00	19.85	5.29	1.32	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	34.37	0.00	0.00	0.00	6.65	0.00	0.00	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	0.00	0.00	0.00	15.71	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	30.23	0.00	0.00	0.00	11.97	0.63	0.00	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	26.29	0.00	0.00	1.55	13.92	0.00	0.00	0.00	3.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	29.27	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	38.12	0.65	1.29	0.65	14.21	1.94	0.00	2.58	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	25.76	3.22	0.00	0.00	11.27	1.61	0.00	1.61	3.22	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	23.90	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	31.78	0.00	1.63	0.00	13.04	0.00	0.00	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	34.00	0.84	0.42	0.84	7.56	0.00	0.42	0.84	0.00	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	19.29	1.61	0.00	0.00	8.84	0.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	24.01	0.92	0.00	0.92	7.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	27.85	1.42	0.00	0.00	3.78	0.00	0.47	0.00	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	24.49	0.00	0.00	0.00	1.81	0.00	0.00	0.91	0.00	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	26.90	1.08	3.23	1.08	7.53	0.00	0.00	0.00	0.00	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	34.30	0.00	0.00	0.00	11.43	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	32.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	33.16	0.00	0.64	0.64	12.75	0.00	0.00	0.64	0.00	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	25.52	0.00	0.00	1.82	9.11	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	29.28	1.43	1.43	0.00	12.14	1.43	1.43	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	0.00	0.00	6.64	13.27	0.00	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	35.50	0.00	0.31	0.93	7.10	0.62	0.31	0.31	0.00	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	40.39	0.00	0.00	0.00	10.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	40.86	0.00	0.00	0.00	9.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	31.99	0.00	0.70	0.00	17.38	0.70	0.00	0.70	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	39.84	0.00	0.00	2.21	19.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	55.11	0.00	3.24	0.00	19.45	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	61.91	0.00	0.00	1.74	17.44	0.87	0.00	2.62	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	69.74	0.00	0.00	2.25	38.25	0.00	2.25	4.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	73.18	0.00	0.00	0.00	34.85	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	50.14	0.00	0.00	1.07	27.74	0.00	0.00	4.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	54.03	0.00	1.39	0.00	19.40	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	54.14	0.00	0.00	0.00	28.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	67.19	1.84	0.00	1.84	16.57	1.84	0.00	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	3.03	0.00	0.00	27.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	111.76	6.21	0.00	0.00	49.67	18.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	83.53	1.06	1.06	1.06	38.07	1.06	0.00	2.11	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	40.80	5.79	1.31	1.55	0.41	0.16	1.39	0.41	1.55	0.16
Keratinocyte - epidermal, donor2	11349-117G8	60.91	5.27	0.59	1.17	2.34	1.17	1.17	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	42.12	6.06	1.23	1.14	0.57	0.09	3.03	0.47	1.80	0.00
Keratinocyte - oral, donor1	11251-116E9	74.81	7.04	3.75	3.75	0.45	0.91	4.43	0.68	2.50	0.34
Keratocytes, donor1	11527-119I6	145.10	5.85	13.07	7.56	1.38	4.13	3.09	4.81	1.38	1.03
Keratocytes, donor2	11607-120I5	19.92	0.00	4.69	2.34	2.34	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	63.63	2.17	5.73	5.34	0.40	2.57	3.75	2.96	1.58	0.99
Krukenberg tumor cell line:HSKTC	10687-109F3	105.50	8.79	2.20	2.20	0.00	0.00	2.20	0.00	0.00	19.78
Lens Epithelial Cells, donor1	11529-119I8	18.34	0.00	0.00	0.00	0.00	0.00	0.00	1.08	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	40.02	2.08	3.00	1.85	1.04	0.81	0.81	1.04	0.58	0.35
Lens Epithelial Cells, donor3	11690-122I7	41.17	0.50	2.32	1.61	0.71	0.50	0.40	0.50	0.71	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	28.58	0.83	1.54	1.78	0.47	0.95	0.47	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	31.26	0.00	1.12	3.63	0.56	1.12	0.28	0.00	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	23.30	0.47	0.94	1.57	0.00	0.79	0.31	0.63	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	27.96	0.00	1.08	0.54	0.54	0.54	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	21.43	0.63	0.32	2.84	0.00	1.58	0.00	0.63	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	18.87	0.11	0.86	0.97	0.32	2.05	0.22	0.75	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	20.52	0.00	1.23	1.23	0.00	0.00	0.82	0.82	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	35.14	0.25	1.52	4.80	0.25	2.02	0.25	0.51	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	18.58	0.84	0.42	1.55	0.28	0.99	0.14	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	32.83	0.40	0.79	0.79	0.00	0.40	0.00	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	45.76	0.00	0.58	3.30	1.36	1.36	0.58	0.78	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	17.40	0.37	0.56	1.48	1.11	0.93	0.37	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	28.22	0.70	1.05	1.74	0.00	0.70	0.70	0.70	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	38.64	0.95	0.72	3.34	1.43	1.19	0.72	0.95	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	23.35	0.14	0.41	2.20	0.55	0.55	0.27	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	34.80	0.62	0.92	2.46	0.92	1.85	0.00	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	23.38	0.00	1.25	1.87	0.94	1.56	0.00	0.94	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	19.76	0.55	0.37	1.83	0.37	1.28	0.55	0.55	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	30.61	0.00	0.66	3.95	0.00	0.00	0.00	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	36.90	0.29	0.88	2.64	1.46	0.88	0.00	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	22.65	0.25	0.50	0.75	0.50	0.50	0.00	0.50	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	36.37	0.00	1.45	2.42	0.00	0.97	0.97	1.45	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	43.63	0.00	0.54	5.12	0.27	1.35	0.00	1.35	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	22.25	0.00	0.30	1.51	0.76	1.21	0.00	0.76	0.00	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	34.22	0.00	0.00	0.52	0.00	1.56	1.04	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	47.95	0.42	1.47	5.86	1.26	2.09	1.05	1.26	0.21	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	26.16	0.15	0.00	1.20	0.75	0.90	0.30	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	32.33	0.69	0.00	1.38	0.69	2.06	0.69	1.38	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	49.11	0.19	0.56	3.57	0.56	1.69	0.00	0.38	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	27.36	0.32	0.74	2.12	0.85	1.17	0.53	0.32	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	33.92	1.45	0.00	2.91	0.48	2.42	0.00	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	42.34	0.33	0.33	3.97	0.00	0.33	0.33	1.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	27.63	0.74	0.87	1.73	0.37	0.37	0.50	0.12	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	34.43	0.37	0.00	2.22	0.00	0.74	0.37	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	41.51	0.25	1.73	2.22	0.25	0.25	0.49	0.49	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	27.50	0.00	0.69	1.65	0.00	0.82	0.55	0.55	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	33.77	0.96	0.96	1.29	0.64	0.00	0.00	0.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	41.39	0.30	0.61	4.56	0.30	1.52	0.61	0.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	34.15	0.56	1.68	1.54	0.28	1.26	0.28	0.56	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	28.09	1.07	0.71	0.71	0.71	0.36	0.36	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	43.63	0.97	0.48	4.85	0.48	1.45	0.00	2.91	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	23.19	0.31	0.78	1.71	0.16	0.62	0.47	0.16	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	33.66	0.72	0.72	2.86	1.07	0.00	0.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	40.83	0.33	0.65	2.61	0.98	0.98	0.00	0.65	0.33	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	17.42	0.24	0.71	0.94	0.94	0.24	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	23.14	0.87	0.87	2.72	0.87	0.50	0.00	0.50	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	34.58	0.00	0.00	4.35	1.28	0.51	0.00	1.28	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	25.36	0.90	0.90	2.09	0.60	0.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	88.37	0.00	6.80	6.80	6.80	0.00	4.53	4.53	0.00	11.33
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	75.95	1.53	3.84	0.00	3.07	3.07	2.30	1.53	0.77	16.11
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	63.83	0.00	2.23	1.48	2.97	0.00	1.48	0.00	0.74	5.20
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	95.63	0.85	2.12	2.12	4.23	0.85	0.85	0.85	1.69	10.58
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	84.40	1.41	0.70	2.81	2.11	2.81	2.11	2.11	0.00	7.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	84.06	0.00	3.74	2.80	1.87	0.93	0.93	0.93	0.00	13.08
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	71.11	0.00	0.52	1.03	1.03	0.52	0.00	1.03	0.52	5.15
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	68.99	0.00	2.38	1.19	2.38	0.00	1.19	2.38	0.00	9.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	90.70	1.58	2.49	2.49	1.13	1.13	0.68	1.81	0.68	3.17
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	59.33	0.29	3.78	0.58	2.62	0.87	1.16	0.00	0.87	3.20
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	63.02	0.45	4.50	1.80	2.70	0.45	0.00	1.35	0.45	5.85
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	108.80	1.08	3.93	1.49	1.08	1.22	1.76	1.63	0.95	3.52
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	78.57	0.51	0.00	2.57	4.11	1.03	0.51	1.54	0.00	4.11
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	59.99	0.00	2.82	1.06	1.76	0.35	1.41	0.71	0.71	5.29
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	67.30	1.33	2.00	1.33	0.67	0.67	1.33	0.00	0.00	5.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	77.43	0.51	3.57	0.00	2.55	1.02	0.51	2.04	1.02	4.58
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	65.37	0.00	1.33	1.33	1.33	1.33	0.80	0.80	0.53	4.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	67.83	0.38	2.65	0.94	1.13	0.76	1.89	0.38	0.19	4.53
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	94.49	0.00	1.23	1.23	6.14	1.84	2.45	0.61	1.23	6.14
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	95.40	0.82	3.26	3.26	4.08	0.82	4.08	0.00	2.45	8.15
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	63.10	0.62	2.29	0.83	1.04	1.04	1.67	0.83	0.42	4.16
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	59.14	0.28	0.84	2.24	4.20	0.84	1.40	0.56	0.00	3.64
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	89.64	2.06	1.03	3.09	2.06	1.03	2.06	1.03	1.03	9.27
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	64.16	0.58	2.32	1.74	2.32	0.87	0.58	0.87	0.87	2.61
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	56.80	1.20	1.49	2.09	1.79	0.90	0.60	0.90	0.30	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	69.16	1.66	2.21	1.11	1.11	2.21	2.21	0.55	0.55	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	91.55	1.41	2.47	1.77	1.77	0.35	1.06	1.41	0.00	6.36
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	70.81	0.74	1.84	1.11	4.79	1.11	1.11	1.48	0.37	6.64
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	81.74	1.15	2.30	0.00	0.00	3.45	2.30	1.15	0.00	9.21
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	84.81	0.77	4.61	2.30	2.69	1.15	0.38	0.38	1.54	6.52
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	96.24	1.13	2.83	2.83	5.66	0.00	0.00	2.83	0.57	4.53
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	81.23	0.00	4.10	0.00	4.10	1.64	1.64	0.82	0.00	7.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	100.77	1.36	2.71	0.45	1.36	0.90	0.90	0.90	0.45	7.23
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	98.39	0.72	5.03	0.72	1.44	0.72	0.72	0.72	0.72	7.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	76.18	1.49	2.24	0.75	3.73	2.99	1.49	0.00	0.00	10.46
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	102.19	1.11	2.60	1.49	2.97	2.23	2.23	1.86	1.11	14.12
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	83.13	0.00	2.58	0.43	2.58	0.43	1.29	0.43	0.00	4.31
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	113.89	0.00	2.57	2.57	5.14	0.00	0.00	3.43	1.71	8.56
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	110.28	0.67	3.33	2.67	2.67	1.00	0.67	1.33	0.33	14.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	127.90	0.60	0.60	1.81	4.22	0.60	1.21	0.60	2.41	9.65
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	99.54	0.71	2.13	2.13	3.55	1.42	2.13	1.42	0.00	19.20
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	97.96	0.00	3.78	1.03	4.12	1.37	2.41	2.06	1.03	11.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	126.67	1.07	2.15	1.61	3.22	1.61	1.61	1.07	0.54	15.57
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	96.96	0.00	1.35	4.04	3.37	1.35	1.35	1.35	0.67	14.14
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	114.83	0.74	2.22	1.48	5.19	0.37	1.85	2.22	0.74	7.41
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	141.88	0.00	3.49	3.49	4.65	1.16	0.00	1.16	0.00	8.14
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	105.77	0.00	3.17	2.12	4.23	1.06	1.06	2.12	0.00	19.04
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	102.04	0.40	2.00	2.80	2.80	0.40	1.60	0.40	1.20	7.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	104.67	0.00	2.91	2.91	6.54	2.91	0.73	2.91	0.00	15.99
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	105.78	1.53	9.20	1.53	9.20	0.77	3.07	1.53	0.00	22.23
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	104.08	1.48	3.45	2.96	5.92	0.49	0.99	0.99	0.49	13.32
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	94.09	0.94	2.82	0.94	3.76	3.76	0.94	0.94	0.94	5.65
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	91.51	0.00	1.01	1.51	6.54	2.51	2.51	1.51	0.00	9.55
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	90.12	0.45	2.70	4.06	2.70	1.35	1.80	1.35	0.45	8.11
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	106.71	0.00	0.00	0.00	0.00	1.72	5.16	1.72	0.00	10.33
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	106.88	0.89	2.67	3.12	2.67	2.23	0.45	1.34	0.00	6.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	98.15	1.96	3.13	4.30	4.69	0.78	0.78	1.96	0.78	5.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	81.15	1.98	0.66	2.64	1.98	1.32	2.64	0.00	0.00	7.26
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	107.94	1.04	3.11	1.04	2.08	3.11	1.56	1.04	2.08	12.97
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	103.27	0.88	4.38	3.50	3.06	1.75	2.19	0.88	0.00	7.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	88.90	0.56	5.03	0.56	3.91	0.56	1.68	1.12	1.12	4.47
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	85.68	0.88	1.77	2.21	2.65	2.65	0.44	1.32	0.00	4.86
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	92.19	1.16	3.47	1.93	1.93	0.77	1.16	1.54	0.77	9.26
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	94.69	0.00	2.03	1.01	3.04	0.51	0.51	0.51	0.00	6.08
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	84.59	1.44	1.44	2.40	4.33	1.92	0.96	3.36	0.00	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	100.18	1.99	2.39	2.78	3.18	1.19	1.99	0.80	0.40	4.37
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	90.54	0.00	3.65	1.82	4.86	0.00	1.22	2.43	0.61	5.47
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	66.40	0.69	2.77	5.53	2.77	1.38	0.00	1.38	0.69	4.15
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	92.34	0.38	1.14	2.66	3.80	1.14	1.14	1.90	1.14	5.32
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	102.77	1.03	5.16	2.58	3.10	1.03	0.52	3.10	1.55	7.23
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	90.09	0.60	3.02	0.60	3.63	0.60	0.60	0.60	0.60	3.02
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	90.00	1.27	1.27	2.54	2.22	1.90	2.54	0.95	0.63	3.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	113.01	1.60	4.26	4.80	2.67	2.13	2.67	0.00	1.07	5.33
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	108.04	0.57	2.87	1.72	3.45	3.45	1.72	2.87	0.57	4.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	111.07	1.54	3.09	3.60	2.06	0.51	0.00	1.03	1.03	6.69
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	93.37	2.83	0.71	1.41	1.41	0.00	3.54	2.12	0.00	4.95
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	98.74	0.57	1.70	0.57	4.54	0.57	0.57	2.27	0.00	5.67
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	104.01	0.83	4.16	2.08	2.50	2.50	2.08	0.42	0.42	6.24
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	85.35	0.00	4.70	1.57	3.92	2.35	2.35	2.35	0.78	4.70
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	97.29	0.84	3.34	0.84	3.34	2.51	1.67	1.25	0.42	4.59
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	99.90	1.39	2.79	2.32	3.25	1.86	0.93	1.39	0.93	6.04
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	80.29	0.67	1.34	0.67	4.68	2.01	3.35	2.68	2.01	6.69
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	86.61	1.07	2.14	2.14	1.60	1.07	0.00	0.53	1.07	8.02
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	101.83	0.40	3.23	0.81	3.64	1.62	0.81	1.62	0.81	3.23
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	84.43	0.92	3.67	0.92	1.84	1.84	1.84	0.92	0.92	9.18
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	98.69	1.78	1.78	2.67	2.67	0.89	1.78	0.00	0.00	9.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	102.58	1.71	2.85	2.28	3.42	1.71	2.85	1.14	0.00	9.12
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	101.23	0.00	3.83	0.00	5.37	1.53	1.53	1.53	1.53	7.67
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	85.36	0.00	1.64	1.64	1.64	2.74	0.55	0.55	0.55	5.47
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	95.77	2.67	4.01	2.23	1.78	0.45	0.89	1.34	0.89	8.91
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	119.06	1.04	2.86	2.08	2.08	1.82	0.78	1.82	0.52	2.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	107.42	1.33	1.99	1.99	1.99	1.99	1.33	0.00	0.00	8.62
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	103.93	0.00	2.08	4.16	2.08	2.08	2.08	2.08	0.00	10.39
Macrophage - monocyte derived, donor1	11232-116C8	17.55	0.68	1.37	0.46	0.23	2.05	0.91	1.60	0.68	0.23
Macrophage - monocyte derived, donor2	11313-117C8	15.05	0.18	1.10	0.55	0.00	2.75	0.55	1.84	0.37	0.00
Macrophage - monocyte derived, donor3	11389-118C3	14.55	0.52	1.05	0.92	0.79	3.67	0.26	2.62	0.52	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	44.07	7.97	2.12	2.12	0.53	0.53	0.00	0.00	2.12	0.00
Mallassez-derived cells, donor2	11929-125I3	49.28	2.54	1.90	1.11	0.63	0.00	1.27	0.00	1.11	0.00
Mallassez-derived cells, donor3	11930-125I4	61.02	4.86	2.36	1.11	0.97	0.69	1.39	0.42	0.83	0.28
Mammary Epithelial Cell, donor1	11273-116H4	111.20	13.25	4.28	6.18	1.89	0.50	2.69	0.50	2.99	0.00
Mammary Epithelial Cell, donor2	11350-117G9	88.02	5.50	2.61	3.19	1.16	0.87	2.32	0.58	1.16	0.29
Mammary Epithelial Cell, donor3	11422-118F9	70.09	6.73	1.00	2.00	2.49	0.25	3.49	0.25	3.74	1.25
Mast cell - stimulated, donor1	11487-119E2	242.70	3.39	1.36	10.85	0.68	3.39	6.78	3.39	0.68	1.36
Mast cell, donor1	11563-120D6	1.51	0.22	0.11	0.00	0.00	0.54	0.00	0.11	0.00	0.22
Mast cell, donor2	11565-120D8	119.17	4.75	5.05	1.19	22.59	7.13	1.49	4.16	2.08	19.91
Mast cell, donor3	11566-120D9	116.16	2.25	3.60	1.80	40.30	11.93	1.13	4.05	1.58	10.58
Mast cell, donor4	11567-120E1	44.14	2.30	1.95	1.06	8.16	5.14	1.77	2.66	1.24	18.62
Mast cell, expanded and stimulated, donor5	11940-126A5	6.54	0.44	0.11	0.00	1.00	1.77	0.44	0.89	0.55	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	18.68	0.58	0.58	0.00	1.17	4.67	0.58	6.42	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	0.69	0.46	0.11	0.00	0.00	0.57	0.00	0.11	0.11	0.00
Mast cell, expanded, donor8	11941-126A6	1.34	0.17	0.17	0.00	0.17	0.84	0.33	0.33	0.17	0.50
Melanocyte - dark, donor1	11502-119F8	25.77	0.99	1.39	0.40	0.60	0.99	0.20	0.70	0.20	0.00
Melanocyte - dark, donor2	11582-120F7	32.53	0.69	4.15	4.85	1.38	0.69	1.38	0.00	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	32.09	4.35	0.87	0.87	1.09	2.32	1.38	1.88	1.59	0.00
Melanocyte - light, donor1	11274-116H5	35.97	2.35	1.18	2.12	1.18	0.00	0.94	0.94	0.24	0.47
Melanocyte - light, donor2	11351-117H1	30.03	2.73	1.36	0.68	0.68	2.05	0.00	0.68	0.68	0.00
Melanocyte - light, donor3	11423-118G1	28.62	2.60	0.87	1.73	0.87	0.00	0.87	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	31.45	7.50	1.35	1.46	0.10	2.50	1.77	1.67	2.92	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	46.26	5.92	1.61	1.61	0.27	0.81	1.61	1.34	1.34	1.34
Melanocyte, donor3 (MC+3)	12837-137B2	21.43	3.21	1.07	0.54	0.00	1.61	2.14	1.34	0.80	0.00
Meningeal Cells, donor1	11493-119E8	32.63	1.12	1.74	0.87	0.37	0.99	0.62	1.24	0.37	0.25
Meningeal Cells, donor2	11573-120E7	11.00	0.00	1.32	0.44	0.00	0.00	0.00	0.00	0.88	0.44
Meningeal Cells, donor3	11654-122E7	18.99	0.24	1.39	0.90	0.57	0.24	0.65	0.65	0.49	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	17.11	0.86	2.00	0.29	0.57	0.29	0.00	0.29	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	40.35	0.81	1.71	2.62	0.10	0.50	1.61	1.21	0.70	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	19.71	1.31	3.94	1.31	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	0.00	0.00	2.62	0.00	1.31	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	22.25	1.44	1.44	0.00	1.44	0.72	1.44	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	39.81	1.06	3.18	2.54	0.00	0.21	2.75	0.64	1.06	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	28.65	1.51	1.51	2.01	0.50	0.00	1.51	0.50	0.50	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	25.49	0.88	3.30	0.22	0.44	1.10	0.66	0.22	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	12.42	2.19	1.46	0.73	0.00	0.73	0.00	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	17.60	0.20	1.23	0.41	0.20	0.61	0.00	0.41	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	29.36	0.69	5.96	0.97	0.69	1.39	0.28	0.83	0.55	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	24.53	1.12	2.60	2.23	0.37	0.37	1.86	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	27.63	0.26	5.13	4.21	1.71	0.53	1.97	0.53	0.53	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	20.18	0.89	1.48	1.19	0.30	0.59	1.48	0.59	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	23.36	0.00	0.00	0.00	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	24.34	0.00	3.20	1.92	0.64	0.00	0.00	1.28	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	40.76	0.71	1.42	2.48	1.77	1.77	0.71	0.71	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	28.15	0.31	5.32	3.44	1.25	0.63	0.63	0.94	0.63	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	27.58	1.45	4.35	2.18	4.35	2.90	2.18	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	27.05	0.80	1.06	2.65	0.53	0.53	0.00	0.80	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	31.53	0.50	2.00	2.50	0.50	1.50	1.50	0.50	0.00	1.00
Mesothelial Cells, donor3	11402-118D7	17.42	0.65	1.01	1.37	0.14	0.58	1.30	0.22	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	9.45	0.00	0.00	0.00	1.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	11.57	0.49	0.49	0.25	0.74	1.97	0.49	1.97	0.25	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	13.25	0.00	0.00	0.00	0.00	2.36	0.00	2.06	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	10.54	0.62	0.00	0.00	0.62	4.34	0.93	0.31	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	11.82	0.41	0.62	0.00	0.41	1.66	0.21	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	0.00	0.00	0.00	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	12.26	1.00	0.75	0.50	0.50	2.75	0.50	1.75	0.50	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	13.96	0.47	0.00	0.00	0.00	1.40	0.93	1.40	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	13.41	0.00	0.20	0.20	0.61	2.24	0.61	1.83	0.20	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	12.67	0.79	0.00	0.79	0.00	1.19	0.79	0.40	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	0.88	0.88	0.00	1.77	0.88	0.00	3.54	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7.98	1.14	0.38	0.00	0.00	1.14	1.14	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	1.32	0.00	0.00	0.00	0.00	1.32	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	11.67	0.00	0.64	0.64	0.42	2.55	0.42	2.76	0.00	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	5.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	5.37	0.89	0.00	0.30	0.00	2.09	0.60	1.19	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	0.00	0.00	0.00	0.00	0.00	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	13.80	0.25	1.00	0.25	0.25	3.26	2.26	1.51	0.25	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	4.04	0.00	0.24	0.00	0.00	1.19	0.48	0.95	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.95	0.00	0.00	0.00	0.00	3.32	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	9.44	1.15	0.46	0.00	0.23	2.99	1.15	1.84	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	4.21	0.21	0.21	0.00	0.00	1.05	0.42	0.63	0.00	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.10	0.20	0.00	0.00	0.00	1.02	0.82	0.61	0.00	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	10.94	0.21	0.64	0.43	0.00	1.07	1.07	1.07	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	4.22	0.00	0.00	0.22	0.00	0.44	0.22	0.67	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	6.79	0.44	0.44	0.44	0.22	2.63	0.44	0.66	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.06	0.00	0.51	0.00	0.00	0.51	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	0.00	0.00	0.00	0.00	1.66	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	6.79	0.27	0.00	0.27	0.00	0.82	1.63	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	4.71	0.29	0.00	0.59	0.00	0.59	0.59	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	0.00	0.00	0.00	1.09	1.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	13.46	0.48	0.00	0.00	0.96	0.48	0.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.00	0.00	0.80	0.00	0.00	1.60	1.20	0.80	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	11.01	2.00	1.50	0.50	0.00	2.50	0.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	0.00	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	18.39	0.00	0.00	0.88	0.00	1.75	1.75	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	13.24	0.00	0.00	0.00	1.10	0.00	0.00	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.25	0.00	0.00	0.64	0.00	2.56	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21.32	0.50	0.50	0.25	0.00	3.72	0.50	1.74	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	16.01	0.00	0.00	0.00	0.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	22.10	0.00	0.00	0.00	0.00	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	35.21	0.34	1.03	0.34	0.68	2.74	0.68	1.37	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	13.13	0.00	0.44	0.00	0.00	1.31	0.88	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	19.18	0.00	0.00	0.00	0.71	2.84	0.36	0.36	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	28.34	0.00	0.28	1.12	1.68	3.65	0.84	1.96	0.28	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	11.22	0.00	0.00	0.42	0.00	1.25	0.00	0.83	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	13.99	0.00	0.00	0.00	0.00	2.91	1.75	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	23.53	0.60	0.30	0.90	0.90	2.11	0.90	1.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	17.11	0.00	0.00	0.00	0.83	0.83	0.00	1.67	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	21.24	0.92	0.00	0.92	0.00	0.00	0.00	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	20.49	0.57	0.57	0.00	0.00	3.41	1.14	2.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	20.45	0.41	0.00	0.41	1.24	1.66	0.69	0.97	0.14	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	24.36	0.00	0.78	1.04	0.26	2.07	0.00	2.33	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	22.31	0.00	1.29	0.00	0.86	2.14	0.86	1.29	0.00	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	12.70	0.00	0.64	0.00	0.64	2.54	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	18.15	0.53	0.00	0.00	0.27	1.87	0.27	2.14	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	33.23	0.90	0.60	1.50	1.20	4.19	1.80	1.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	23.87	0.14	0.57	0.14	1.27	2.26	0.57	1.84	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	30.26	0.96	0.32	0.64	0.96	2.55	0.96	1.27	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	20.34	0.44	0.66	0.44	0.44	1.99	0.44	1.77	0.22	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	18.58	0.00	0.38	0.38	0.76	2.28	0.38	0.76	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	23.01	0.28	0.85	0.00	1.14	2.27	0.85	1.99	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	29.00	0.25	0.25	0.74	0.98	5.16	0.74	2.46	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	26.72	1.30	0.00	0.00	0.65	3.91	0.65	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	22.93	0.00	1.47	0.59	0.29	2.94	0.00	0.88	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	33.73	0.86	1.44	0.58	1.73	3.75	0.58	2.88	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	44.92	0.82	0.00	0.82	2.47	2.89	0.82	2.47	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	34.54	0.30	0.30	1.79	1.49	3.28	1.49	2.68	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	0.00	0.00	3.77	3.77	3.77	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	19.60	0.00	0.00	0.00	1.78	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	19.06	0.33	0.33	0.00	1.64	2.63	0.99	1.64	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	13.68	0.00	0.00	2.10	3.16	3.16	1.05	5.26	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	11.86	0.20	0.99	0.20	0.00	3.76	0.59	2.17	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	27.01	1.86	0.00	0.00	1.86	2.79	0.00	1.86	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	13.89	0.38	1.13	0.38	1.50	2.25	0.00	1.50	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	13.05	1.07	0.80	0.00	0.80	1.86	0.80	1.33	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	31.78	0.90	0.34	0.00	0.11	4.41	0.23	2.71	0.34	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	16.94	0.00	1.47	0.74	0.00	2.95	0.00	0.74	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	27.85	1.10	1.47	0.00	1.83	4.03	1.47	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	0.00	3.11	0.00	0.00	0.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	11.76	0.00	1.07	0.00	0.00	3.21	1.07	1.07	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	3.86	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	19.19	2.02	0.00	1.01	1.01	3.03	1.01	3.03	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	3.79	0.84	0.42	0.00	0.00	4.64	0.42	0.84	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	38.13	1.36	5.45	6.81	8.17	4.09	2.72	1.36	1.36	29.96
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	23.52	1.27	5.09	0.64	2.54	3.81	3.18	1.27	2.54	6.99
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.91	0.00	0.81	0.81	10.53	1.62	0.00	1.62	1.62	6.48
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	1.51	1.51	0.00	1.51	6.04	4.53	0.00	1.51	10.57
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	125.62	22.84	28.55	22.84	5.71	0.00	22.84	5.71	5.71	114.20
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	169.65	9.79	39.15	52.20	16.31	9.79	9.79	9.79	3.26	29.36
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	90.30	0.00	14.26	9.50	0.00	4.75	4.75	9.50	0.00	19.01
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	0.00	0.00	0.00	12.55	0.00	0.00	25.10
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	22.84	1.72	1.29	1.51	0.00	0.43	0.65	0.22	0.43	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	21.95	0.52	2.61	1.05	0.00	2.09	1.57	0.52	0.52	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	3.34	0.67	1.33	2.67	1.33	0.00	1.33	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	8.76	0.83	0.00	0.00	1.25	0.00	1.25	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	33.46	1.14	2.09	0.95	3.04	0.76	0.57	0.19	0.57	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	30.32	0.00	3.19	0.00	1.60	0.00	3.19	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.76	0.00	0.68	0.00	1.36	0.00	2.04	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	49.62	3.68	5.51	3.68	1.84	0.00	7.35	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	8.79	0.42	1.26	0.42	2.93	0.42	1.26	0.42	0.42	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	5.35	0.93	0.46	0.23	1.39	0.00	0.93	0.23	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	7.30	2.16	1.62	0.81	1.62	0.81	0.81	0.27	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	17.45	1.47	1.47	1.05	0.63	0.84	2.10	0.42	0.21	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	0.00	11.13	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	12.41	0.99	5.96	0.00	3.97	0.50	0.99	0.00	0.00	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	17.32	1.08	4.60	1.08	2.17	1.89	0.54	0.27	1.89	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	2.95	0.68	3.63	0.68	2.49	0.45	0.45	0.45	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.21	1.14	2.12	0.65	1.80	0.82	1.63	0.33	0.65	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	18.23	1.82	2.73	2.00	1.64	1.46	2.92	0.36	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	7.96	0.00	5.30	1.59	3.18	1.06	1.59	0.00	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.60	0.00	4.20	1.20	6.00	1.20	0.60	0.60	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	43.32	2.63	4.27	1.64	0.66	0.98	0.66	0.66	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	4.88	1.79	2.76	0.49	2.44	0.49	0.16	0.00	0.33	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	19.40	1.59	2.12	1.41	1.06	1.41	3.00	0.53	0.53	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.03	0.00	1.41	1.41	4.22	0.00	1.41	0.00	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.11	0.46	3.22	0.92	0.00	0.00	0.46	0.46	0.46	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	4.50	1.61	3.53	0.32	1.93	0.64	1.29	0.96	0.96	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	44.49	3.79	6.90	3.45	4.48	1.03	1.72	1.03	0.34	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	98.61	7.59	0.00	0.00	0.00	0.00	2.53	2.53	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	16.93	2.01	2.67	0.67	1.11	0.45	2.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.97	2.96	0.85	0.85	1.27	0.42	2.54	0.00	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	11.87	1.90	4.51	0.95	1.42	0.47	2.85	0.00	0.24	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.01	2.15	1.29	1.29	1.29	0.43	2.58	1.29	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	18.06	0.00	0.00	0.00	0.00	9.03	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.00	1.67	0.67	0.67	0.67	0.67	2.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	12.62	0.45	0.90	0.00	0.45	1.35	2.25	0.45	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	7.54	0.79	1.59	0.79	0.00	0.79	1.98	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	1.86	0.00	1.86	0.00	1.86	0.00	0.93	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	11.35	1.51	3.41	0.38	1.14	1.51	0.76	0.76	1.51	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	6.84	0.98	0.98	0.65	0.98	0.65	1.63	0.33	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	4.36	1.74	1.31	1.31	0.00	0.00	1.31	0.00	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	8.14	1.81	2.26	0.45	0.90	0.90	4.52	0.45	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	4.41	0.88	1.76	0.00	0.88	0.88	0.00	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	4.65	0.66	3.99	1.33	0.66	1.99	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	5.95	1.98	2.48	0.50	0.00	0.99	1.49	0.50	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.21	1.91	2.30	0.38	1.15	0.38	1.15	0.38	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	23.29	3.33	3.63	0.60	4.54	1.51	1.81	0.30	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	16.80	2.21	1.99	0.22	1.77	0.88	1.55	0.44	0.22	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.71	1.36	1.36	0.00	1.36	0.68	2.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	66.42	10.22	5.11	5.11	0.00	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	0.61	2.44	3.05	0.61	0.61	1.22	0.61	0.00	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.35	0.00	1.57	0.00	1.26	1.57	0.63	0.63	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	5.45	0.30	1.51	0.30	2.12	0.00	2.12	0.00	0.30	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	4.75	1.58	2.37	0.00	2.37	0.00	3.16	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	35.14	0.00	5.67	1.13	0.00	2.27	3.40	0.00	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	35.41	15.17	5.06	0.00	0.00	0.00	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	17.39	1.37	1.86	2.86	0.37	0.37	1.24	0.75	0.62	0.50
Myoblast, donor2	11322-117D8	22.63	1.92	2.88	2.11	0.96	0.19	1.15	0.58	0.19	0.77
Myoblast, donor3	11398-118D3	12.78	1.35	2.35	1.68	0.67	0.50	2.19	0.50	0.84	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	5.11	0.15	0.00	0.00	0.00	1.31	0.00	0.44	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	22.14	1.54	0.62	0.00	10.76	8.30	0.00	2.46	1.54	11.38
Natural Killer Cells, donor2	11311-117C6	26.54	1.21	1.21	0.00	15.08	6.33	0.00	3.02	1.21	26.84
Natural Killer Cells, donor3	11387-118C1	20.43	0.92	0.18	0.18	14.54	6.81	0.00	1.66	1.47	29.63
Neural stem cells, donor1	11275-116H6	43.19	4.72	5.08	9.44	0.73	0.73	4.36	0.00	1.45	0.00
Neural stem cells, donor2	11352-117H2	17.33	1.93	5.78	11.55	0.00	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	19.34	4.55	3.41	5.69	3.41	2.28	5.69	0.00	1.14	2.28
Neurons, donor2	11574-120E8	22.24	0.88	1.76	5.28	0.44	0.44	2.64	0.66	0.44	0.00
Neurons, donor3	11655-122E8	12.33	1.64	3.29	7.40	5.76	0.00	0.82	0.82	0.82	0.82
Neutrophils, donor1	11233-116C9	8.35	0.00	0.00	0.00	0.93	1.86	0.00	1.86	0.00	2.78
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00	0.00	2.90	0.00	0.00	2.90	0.00	2.90
Neutrophils, donor3	11390-118C4	9.16	0.00	0.00	0.00	2.44	3.05	0.00	1.83	0.00	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	39.66	0.95	5.82	2.37	0.47	0.95	1.54	0.59	0.36	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	13.02	0.33	5.21	0.33	0.65	0.33	1.30	0.33	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	30.08	1.00	1.80	1.80	0.60	0.80	1.80	0.40	0.20	0.40
Olfactory epithelial cells, donor1	11933-125I7	13.21	0.55	0.55	0.83	0.00	0.28	0.69	0.96	0.96	0.14
Olfactory epithelial cells, donor2	11934-125I8	17.22	1.30	2.32	2.32	1.74	1.01	3.18	0.58	1.01	0.72
Olfactory epithelial cells, donor3	11935-125I9	14.07	1.70	2.84	0.91	0.57	0.68	1.25	1.14	1.14	0.34
Olfactory epithelial cells, donor4	11936-126A1	17.82	1.07	2.92	1.07	0.10	1.07	1.46	0.49	0.49	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	42.13	2.41	0.60	4.81	1.20	0.60	0.00	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	17.87	1.70	2.34	0.85	0.21	1.06	0.43	1.06	1.06	0.43
Osteoblast - differentiated, donor2	11353-117H3	18.29	0.00	2.29	2.29	0.00	0.00	2.29	0.00	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	27.93	5.59	4.97	1.86	1.24	0.62	4.97	0.00	1.24	1.24
Osteoblast, donor1	11277-116H8	40.06	1.37	0.78	2.54	1.56	0.78	1.37	0.20	0.59	0.20
Osteoblast, donor2	11354-117H4	37.93	2.11	1.40	3.51	0.70	1.40	0.70	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	48.34	1.24	1.60	3.20	1.07	0.36	2.13	0.00	0.53	0.18
Pancreatic stromal cells, donor1	11249-116E7	19.37	2.36	6.82	1.26	0.51	0.67	3.12	0.08	0.59	0.00
Pericytes, donor1	11491-119E6	19.03	0.67	1.34	0.33	0.45	0.11	0.22	0.22	0.11	0.11
Pericytes, donor2	11571-120E5	17.20	1.36	1.58	0.68	0.00	0.23	2.26	0.45	0.91	0.45
Pericytes, donor3	11652-122E5	32.96	0.81	2.44	3.87	0.41	1.22	0.61	0.20	0.20	0.00
Perineurial Cells, donor1	11499-119F5	28.59	1.24	2.94	2.37	0.90	1.02	0.90	0.34	0.00	0.23
Perineurial Cells, donor2	11579-120F4	31.65	0.74	5.70	4.88	1.29	0.74	1.38	0.37	0.64	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	27.73	0.64	0.96	0.00	8.61	4.14	0.00	3.19	0.96	3.19
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	21.55	1.22	0.24	0.00	19.83	6.37	0.49	2.45	1.22	7.84
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	39.21	1.16	0.39	0.78	10.87	4.92	0.26	2.72	0.65	2.85
Placental Epithelial Cells, donor1	11278-116H9	62.18	6.22	1.43	4.07	0.72	0.48	2.63	0.48	1.67	0.00
Placental Epithelial Cells, donor2	11355-117H5	38.81	1.11	2.22	2.22	1.11	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	42.80	2.36	0.59	0.00	0.79	0.79	2.75	0.98	1.37	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	17.72	3.16	0.95	0.95	0.00	1.90	2.85	0.95	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	33.39	4.50	2.44	3.19	0.38	1.31	2.06	0.94	1.69	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	27.41	2.48	4.57	2.48	1.44	2.87	0.65	1.04	0.65	0.39
Preadipocyte - breast, donor2	11328-117E5	20.94	2.70	2.93	2.03	0.45	0.68	2.93	0.00	0.90	0.00
Preadipocyte - omental, donor1	11468-119C1	52.64	5.97	2.98	6.93	0.75	1.70	2.88	2.24	3.41	0.32
Preadipocyte - omental, donor2	11329-117E6	25.75	3.06	3.49	1.31	0.44	2.62	1.31	1.75	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	52.57	5.44	2.86	4.58	0.29	1.58	3.15	1.86	1.86	0.43
Preadipocyte - perirenal, donor1	11469-119C2	73.82	3.94	1.97	9.84	0.98	0.00	1.97	0.98	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	32.25	1.23	0.61	1.84	0.92	0.92	2.46	0.00	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	27.80	1.42	2.48	3.01	2.30	0.71	2.12	0.53	0.53	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	28.44	1.53	1.87	1.70	0.68	1.53	3.41	0.85	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	31.20	1.12	3.82	1.30	1.12	0.93	2.14	0.75	0.84	0.09
Preadipocyte - visceral, donor2	11357-117H7	50.16	0.92	4.60	4.60	1.84	2.76	0.92	0.46	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	21.21	0.73	2.93	1.99	1.25	1.04	1.57	0.52	0.52	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	47.07	0.91	6.49	1.36	0.60	0.60	0.60	0.60	0.15	3.77
Prostate Epithelial Cells, donor2	11331-117E8	32.09	3.39	3.79	3.11	0.41	0.54	1.90	0.14	0.14	0.00
Prostate Epithelial Cells, donor3	11404-118D9	43.05	17.64	1.16	1.90	2.20	0.73	3.18	1.78	5.02	2.14
Prostate Stromal Cells, donor1	11254-116F3	34.85	1.03	3.64	3.99	0.80	1.25	2.39	1.48	0.46	0.34
Prostate Stromal Cells, donor2	11332-117E9	51.10	1.79	5.20	3.23	1.26	1.08	3.23	1.26	0.18	0.72
Prostate Stromal Cells, donor3	11405-118E1	18.14	1.04	4.07	1.46	0.10	0.83	2.29	0.94	0.83	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	133.58	1.82	4.74	3.28	1.82	1.82	0.00	2.55	0.73	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	86.22	0.90	2.08	2.43	0.83	0.83	0.42	0.69	0.76	0.49
Renal Epithelial Cells, donor1	11517-119H5	86.23	0.00	0.51	1.52	1.01	0.00	0.51	0.51	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	80.38	0.00	2.13	2.13	0.71	0.71	0.71	1.42	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	87.44	1.16	1.80	2.12	0.95	1.38	0.85	1.06	0.53	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	21.11	0.00	1.36	0.00	2.04	0.00	0.00	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	18.19	0.67	0.81	1.35	0.81	0.54	0.27	0.27	0.27	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	28.42	0.89	0.67	0.44	0.00	0.00	1.11	0.00	0.00	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	20.63	0.00	1.33	2.66	0.67	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	56.34	1.32	1.76	0.66	0.88	0.00	0.44	0.22	0.22	0.66
Renal Mesangial Cells, donor2	11598-120H5	94.05	1.88	3.76	1.88	1.25	0.00	0.00	0.63	1.25	3.13
Renal Mesangial Cells, donor3	11679-122H5	56.87	0.83	1.94	1.94	0.28	0.28	0.83	0.28	0.28	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	121.06	2.15	1.34	2.15	1.07	1.34	0.81	1.61	1.34	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	88.98	0.84	1.27	1.69	0.42	2.53	0.42	0.84	0.84	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	65.76	0.96	1.35	1.35	1.54	1.16	0.77	0.96	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	35.00	1.81	1.30	1.30	1.30	0.52	1.56	0.26	0.78	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	92.66	3.70	2.27	2.84	1.99	0.00	3.98	0.00	0.85	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	36.02	1.03	3.09	2.06	4.12	1.03	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	94.59	1.76	3.01	5.52	0.25	2.26	1.76	1.25	1.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	30.47	2.41	2.41	2.00	1.07	2.00	1.47	1.07	1.07	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	5.36	0.00	0.89	1.79	0.00	0.00	0.89	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	2.20	0.00	0.55	0.00	0.55	0.00	0.55	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	4.06	0.00	0.58	0.00	0.00	1.16	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	13.78	0.39	0.39	0.00	0.26	0.26	0.13	0.52	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	9.43	0.30	0.50	0.79	0.30	0.20	0.10	0.60	0.10	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	9.82	0.45	1.00	0.78	0.00	0.22	0.22	0.45	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	12.03	0.37	0.50	0.12	0.37	0.62	0.12	0.25	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	8.51	0.00	0.58	0.35	0.23	0.35	0.23	0.58	0.12	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	9.48	0.00	0.92	0.46	0.00	0.46	0.00	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	4.65	0.00	0.27	0.55	0.27	0.27	0.14	0.41	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	8.62	0.15	0.30	0.15	0.61	0.15	0.15	0.00	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	7.35	0.00	0.72	0.18	0.00	0.54	0.18	0.36	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	4.73	0.29	0.43	0.72	0.29	0.43	0.00	0.43	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	7.73	0.11	0.32	0.32	0.21	0.54	0.11	0.11	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	4.87	0.89	0.44	0.22	0.00	0.44	0.66	0.22	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	7.07	0.00	0.38	0.38	0.00	0.00	0.19	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	6.34	0.19	0.28	0.37	0.09	0.56	0.19	0.37	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	4.51	0.00	0.19	0.38	0.19	0.19	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	7.03	0.00	0.00	0.00	0.53	0.13	0.00	0.53	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	5.06	0.29	0.39	0.49	0.58	0.39	0.19	0.00	0.10	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	6.49	0.19	0.19	0.38	0.38	0.38	0.19	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	6.30	0.43	0.21	0.43	0.11	0.64	0.43	0.00	0.32	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	4.48	0.00	0.28	0.84	0.00	0.00	0.56	0.28	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	4.44	0.34	0.51	0.51	0.00	0.34	0.17	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	7.84	0.00	0.18	0.55	0.36	0.55	0.18	0.18	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	6.87	0.12	0.12	0.49	0.25	0.61	0.61	0.12	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	7.25	0.27	0.54	0.67	0.13	0.54	0.13	0.27	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	11.56	0.71	0.24	0.00	0.24	0.71	0.71	0.47	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	7.54	0.60	0.79	0.99	0.20	0.60	1.39	0.60	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	5.14	0.00	0.23	0.23	0.23	0.23	0.47	0.23	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	9.12	0.21	0.62	0.83	0.41	0.41	0.21	0.00	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	5.97	0.22	0.44	0.66	0.00	0.88	0.00	0.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	5.64	0.21	0.42	0.42	0.00	0.00	0.42	0.21	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	7.54	0.00	0.13	0.13	0.40	0.67	0.67	0.27	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	7.49	0.17	0.68	0.34	0.17	0.51	0.51	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	5.59	0.19	0.19	0.58	0.39	0.00	0.19	0.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	10.66	0.17	0.52	0.34	0.17	0.69	0.17	0.69	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	9.19	0.00	0.41	0.96	0.69	0.14	0.41	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	8.37	0.00	0.16	0.33	0.33	0.00	0.00	0.49	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	10.91	0.68	0.34	0.34	0.34	0.34	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	10.80	0.00	0.15	0.30	0.30	0.44	0.15	0.44	0.15	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	9.06	0.00	0.53	0.53	0.27	0.27	0.53	0.80	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	8.57	0.28	0.28	0.14	0.28	0.69	0.55	0.00	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	11.91	0.71	0.48	0.00	0.00	0.71	0.48	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	8.67	0.20	0.00	0.00	0.20	0.20	0.60	0.40	0.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	7.63	0.28	0.28	0.09	0.57	0.94	0.19	0.28	0.09	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	12.93	0.35	0.00	0.00	0.35	0.35	0.70	0.70	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	9.37	0.30	0.30	0.30	0.00	0.91	0.60	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	5.39	0.00	0.49	0.12	0.24	0.37	0.12	0.00	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	6.99	0.15	0.44	0.44	0.00	0.58	0.44	0.44	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	9.73	0.00	0.00	0.61	0.61	0.00	0.00	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	6.63	0.00	0.00	0.00	0.00	0.30	0.00	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	12.21	0.45	0.23	0.45	0.23	0.23	0.45	1.13	0.23	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	11.98	0.30	0.90	0.30	0.30	0.30	0.30	0.30	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	8.03	0.35	0.47	0.47	0.24	0.47	0.12	0.35	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	10.67	0.64	0.64	0.21	0.43	0.21	0.43	0.43	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	4.81	0.00	1.20	0.00	0.60	0.00	1.80	0.00	1.20	0.60
Schwann Cells, donor1	11498-119F4	28.02	0.38	0.94	0.75	1.32	1.13	0.38	0.56	0.38	0.00
Schwann Cells, donor2	11578-120F3	23.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	34.40	1.53	1.10	2.41	1.10	0.66	1.10	0.88	0.44	0.00
Sebocyte, donor1	11220-116B5	62.99	10.41	4.93	1.64	0.55	0.55	2.74	1.10	1.10	0.00
Sebocyte, donor2	11301-117B5	41.36	7.35	3.22	2.30	0.46	1.84	5.06	0.46	0.00	0.46
Sebocyte, donor3	11378-118B1	19.99	3.09	3.71	2.47	0.41	1.03	1.86	1.03	0.62	0.21
Sertoli Cells, donor1	11255-116F4	46.38	1.66	0.00	19.88	0.00	3.31	4.97	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	67.78	2.82	2.82	2.82	0.00	0.00	2.82	2.82	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	73.64	4.40	1.50	6.07	1.14	2.02	9.59	1.67	1.23	0.00
Skeletal Muscle Cells, donor2	11358-117H8	52.77	1.45	4.34	4.34	0.72	2.89	5.06	1.45	0.72	1.45
Skeletal Muscle Cells, donor3	11430-118G8	36.79	3.34	0.00	1.67	9.20	1.67	4.18	1.67	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	15.24	0.31	1.10	1.57	0.94	0.47	0.94	0.31	0.47	0.00
Skeletal Muscle Cells, donor5	11455-119A6	17.84	0.30	1.34	1.19	0.89	1.04	0.74	0.74	0.15	0.45
Skeletal Muscle Cells, donor6	11459-119B1	27.09	0.46	0.92	1.54	1.54	2.62	1.85	0.15	0.46	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	33.64	1.01	4.41	3.15	0.25	1.64	0.76	0.76	0.76	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	25.97	0.57	4.14	2.71	0.14	0.86	1.28	0.43	0.14	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	23.51	0.79	1.19	1.98	0.69	1.09	1.29	0.40	0.30	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	29.91	3.79	1.01	1.43	0.84	0.84	4.72	0.25	1.35	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	65.14	0.72	2.17	3.62	0.72	0.72	4.34	0.72	2.17	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	25.46	1.51	1.24	1.93	1.10	0.55	3.16	0.41	0.14	0.41
Skin - palm, donor1	10286-104F7	29.55	2.69	2.69	0.00	0.00	0.00	8.06	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	28.69	3.32	1.59	0.43	0.14	0.14	1.44	0.43	0.86	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	80.15	8.18	2.45	1.64	4.91	1.64	1.64	0.00	2.45	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	19.86	2.73	1.56	0.65	0.65	0.26	1.04	0.39	0.91	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	64.78	6.53	2.92	2.92	0.97	0.42	2.22	0.42	1.39	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	48.53	3.52	1.27	2.67	0.70	0.28	5.06	0.14	0.98	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	63.22	5.71	1.90	2.96	3.17	1.27	0.85	1.06	2.33	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	67.23	6.52	1.12	2.02	0.82	0.82	2.02	1.35	2.32	3.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	47.21	1.85	2.78	6.48	0.31	1.54	1.85	0.93	0.62	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	34.68	0.44	4.22	2.45	4.89	1.33	0.67	1.11	0.22	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	37.62	1.18	2.35	3.53	7.64	1.18	1.76	0.59	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	38.89	0.66	1.99	6.19	0.44	0.22	0.88	0.00	0.44	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	24.41	1.58	2.76	1.97	0.79	0.39	0.00	0.39	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	34.77	3.09	3.86	1.55	0.77	1.55	2.32	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	16.01	0.00	2.00	1.00	0.00	0.00	0.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	23.02	0.27	1.86	2.40	0.67	0.40	0.67	0.27	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	29.48	3.10	2.88	2.88	0.22	1.11	4.65	1.99	0.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	35.72	0.38	0.90	1.54	0.64	0.51	1.54	0.77	1.02	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	13.02	0.33	2.28	0.98	0.00	0.65	0.98	0.33	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	7.97	0.59	0.89	0.00	0.59	0.89	0.59	0.00	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	15.09	0.28	4.13	1.85	0.43	0.43	1.14	1.14	0.14	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	29.93	2.77	2.60	2.60	0.49	0.81	1.46	0.33	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	22.22	0.91	2.74	0.91	0.30	2.13	1.83	0.00	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	32.08	1.01	3.79	3.28	2.27	2.02	0.76	0.25	0.76	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	128.53	0.00	6.12	24.48	0.00	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	27.18	0.00	1.91	2.38	1.91	1.43	1.43	1.43	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	31.26	1.47	4.72	2.36	0.44	0.29	1.92	0.74	0.44	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	20.02	0.65	3.23	1.94	0.00	0.86	1.72	0.22	0.22	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	29.60	0.73	4.41	1.57	0.94	1.68	1.89	0.52	0.21	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	20.11	0.62	1.39	1.86	0.46	0.00	0.46	0.77	0.15	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	22.64	0.00	1.08	0.00	1.08	0.00	0.00	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	34.67	0.90	1.20	2.09	1.20	0.60	1.49	0.30	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	34.82	1.02	1.37	0.68	0.34	1.71	1.71	0.34	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	38.17	0.55	5.50	2.28	0.79	0.86	2.28	1.10	0.16	0.55
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	22.54	1.71	1.91	1.41	0.60	1.91	2.01	0.60	0.50	2.42
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	55.07	3.87	3.87	6.14	0.91	1.14	1.82	1.59	0.68	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	20.53	0.00	1.21	1.21	2.42	0.60	1.21	0.60	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	18.81	0.00	1.59	2.38	0.79	0.53	0.53	0.53	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	23.84	1.07	4.26	1.33	0.80	0.93	1.20	0.27	0.00	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	27.67	1.13	4.38	2.38	0.00	0.75	3.51	0.63	0.75	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	17.76	0.51	2.03	1.27	0.00	1.52	2.03	0.76	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	21.86	2.56	2.11	3.47	0.45	1.06	1.51	0.60	0.45	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	30.76	2.25	5.25	1.50	0.00	0.00	5.25	0.00	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	148.60	0.00	2.58	12.92	1.29	1.29	2.58	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	47.90	1.86	1.86	3.72	1.40	1.40	2.33	1.40	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	18.18	2.02	2.52	2.02	0.00	1.01	1.01	1.01	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	23.19	1.25	2.82	2.19	1.57	1.25	2.19	0.94	0.00	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	13.86	0.29	5.31	0.59	0.00	0.00	0.00	0.29	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	18.33	0.50	1.83	1.33	0.42	0.58	1.42	0.08	0.25	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	26.16	1.40	3.74	0.93	0.93	0.47	2.34	0.47	0.00	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	23.17	0.29	0.72	1.73	0.43	0.72	0.43	0.00	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	24.73	0.51	1.02	1.53	1.78	0.25	0.76	0.76	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	16.92	0.75	0.75	0.38	1.69	0.19	1.13	0.19	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	34.66	0.84	3.91	1.26	1.40	1.82	0.84	1.68	0.42	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	42.31	0.92	3.10	2.93	0.34	2.77	1.09	2.09	0.67	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	35.24	0.00	1.43	0.00	2.38	1.43	0.48	3.33	0.00	2.86
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	21.04	0.98	1.22	0.73	0.49	0.24	0.24	0.98	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	13.26	0.44	1.55	0.66	0.22	0.00	1.10	0.22	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	22.82	1.17	1.17	2.05	1.17	0.59	0.88	0.59	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	16.52	1.55	3.30	0.58	0.97	0.19	3.50	0.78	0.78	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	16.40	0.79	2.12	0.79	0.79	0.26	0.79	0.79	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	5.58	2.60	10.41	0.00	1.12	0.00	1.49	0.37	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	17.25	0.72	6.47	0.36	1.08	0.36	2.52	0.00	0.36	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	15.90	0.57	1.42	1.14	0.28	0.00	1.14	0.00	0.00	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	20.09	0.79	1.97	1.58	3.54	0.79	0.39	0.00	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	23.87	1.78	8.63	4.32	1.27	0.51	4.57	1.02	0.25	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	16.77	2.40	5.59	0.80	0.40	2.00	3.99	1.20	0.00	2.00
Smooth muscle cells - airway, control, donor3	11968-126D6	15.05	0.84	4.18	0.84	0.00	0.84	2.51	0.00	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	33.46	1.83	4.58	1.83	1.38	0.92	4.58	0.46	0.00	4.13
Synoviocyte, donor1	11291-117A4	37.37	3.37	2.19	3.53	0.50	0.50	3.03	1.18	1.35	0.17
Synoviocyte, donor2	11368-117I9	36.21	5.53	5.03	4.86	0.34	2.35	2.68	1.84	1.34	0.67
Synoviocyte, donor3	11440-118H9	23.90	5.59	4.47	2.68	0.00	1.56	1.79	0.89	1.56	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	41.45	1.43	2.14	1.43	1.43	1.43	0.71	1.43	0.36	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	45.59	0.00	9.91	3.96	1.98	0.00	0.00	1.98	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	37.05	1.16	4.40	2.08	0.93	2.32	1.39	0.93	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	64.01	3.08	0.86	1.86	1.22	0.07	1.08	0.57	1.43	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	24.74	1.55	1.16	1.16	1.16	0.00	0.77	0.77	0.00	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	46.96	2.86	2.86	1.72	5.15	0.57	1.72	1.15	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	32.48	1.48	2.34	3.08	0.12	1.11	0.74	1.48	1.35	0.49
Urethra, donor2	10319-105A4	26.98	0.00	1.80	3.60	0.00	0.00	1.80	0.00	3.60	1.80
Urothelial Cells, donor1	11520-119H8	44.90	3.45	1.33	1.33	0.00	0.27	0.53	0.53	0.53	0.00
Urothelial Cells, donor2	11600-120H7	44.46	1.60	1.60	1.20	0.00	0.00	1.20	0.40	0.40	0.40
Urothelial Cells, donor3	11681-122H7	34.84	1.60	1.38	1.15	0.23	0.23	1.15	0.00	0.00	0.46
Urothelial cells, donor0	11216-116B1	48.81	4.01	3.57	1.34	0.22	0.00	0.89	0.22	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	19.58	1.78	0.00	0.00	0.89	2.67	0.00	0.89	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	27.16	4.29	0.00	0.00	0.00	2.86	0.00	2.86	5.72	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	10.95	0.68	0.00	0.00	0.00	2.05	0.00	2.74	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	19.97	2.41	0.00	0.34	0.00	1.03	0.00	1.38	2.07	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	17.43	1.74	0.00	0.00	0.00	0.58	0.00	2.91	2.32	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	23.95	2.08	0.00	0.00	2.08	2.08	0.00	1.04	3.12	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	23.86	0.92	0.00	0.00	0.92	1.84	0.00	2.75	2.75	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	14.61	1.83	0.00	0.00	0.91	1.83	0.00	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	51.32	2.10	3.21	3.33	1.73	0.37	1.85	0.00	0.12	1.11
Wilms' tumor cell line:HFWT	10597-108E3	58.08	7.92	0.88	8.80	0.00	0.00	7.04	0.00	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	72.34	6.42	2.79	3.63	1.96	0.56	3.35	0.28	1.96	0.84
achilles tendon, donor2	10292-104G4	18.60	2.07	0.00	2.07	10.33	0.00	2.07	4.13	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	8.67	0.25	0.00	0.00	0.76	2.29	0.00	0.76	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	33.67	0.46	0.00	0.00	3.02	2.79	0.00	2.79	0.46	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	7.48	0.59	0.00	0.00	0.59	0.83	0.00	0.71	0.24	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	11.43	0.54	0.54	0.00	0.00	1.09	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	3.37	0.00	0.00	0.00	0.00	0.56	0.00	0.84	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	13.11	0.42	0.42	0.00	0.21	3.38	0.00	1.90	1.27	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	13.34	0.00	0.27	0.27	0.27	1.36	0.00	0.54	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	30.40	0.00	0.44	0.44	1.76	5.73	0.88	0.88	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	17.15	0.41	0.00	0.00	0.00	6.13	0.00	3.68	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	18.64	0.00	0.00	0.00	1.94	5.44	0.39	2.33	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	18.22	0.18	0.00	0.00	1.29	5.52	0.37	2.39	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	0.00	0.00	0.00	0.00	0.00	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	7.67	0.23	0.70	0.23	0.23	0.23	0.00	0.23	0.23	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	24.34	0.78	0.00	0.00	4.66	10.10	0.00	4.66	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	17.83	0.58	0.00	0.00	1.17	5.84	0.58	4.97	0.29	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	11.62	0.00	0.00	0.00	1.39	2.79	0.46	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	7.81	0.00	0.00	0.00	0.00	4.11	0.00	3.29	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1.53	0.00	0.31	0.00	0.00	2.15	0.31	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	7.25	0.00	0.00	0.00	1.28	2.56	0.00	2.56	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	4.85	0.30	0.30	0.30	0.30	6.07	0.61	0.91	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	4.57	0.00	0.00	0.24	2.41	5.30	0.24	2.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	5.12	0.22	0.22	0.00	0.89	2.23	0.00	0.89	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	19.35	0.00	0.67	0.00	2.33	0.33	0.33	0.00	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	26.01	0.00	1.86	0.00	1.86	0.00	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	3.77	0.00	0.38	0.00	0.00	1.51	0.38	0.75	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	18.74	1.87	0.00	0.00	1.87	0.00	0.00	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	28.50	1.18	0.71	1.41	2.35	0.24	0.47	0.00	0.71	0.24
adipose tissue, adult, pool1	10010-101C1	24.82	1.40	2.64	3.88	0.47	2.64	0.93	1.71	0.93	0.31
adipose, donor1	10184-103D4	256.85	5.86	23.46	9.97	5.28	1.17	2.93	0.00	1.76	0.00
adipose, donor2	10185-103D5	58.80	1.22	3.24	2.84	9.73	0.41	3.24	1.22	0.41	0.41
adipose, donor3	10186-103D6	65.89	1.09	3.54	1.91	5.17	0.54	3.27	0.82	0.54	0.82
adipose, donor4	10187-103D7	141.28	0.00	4.33	0.00	3.47	1.73	0.00	2.60	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	20.36	0.47	2.21	1.26	0.63	0.00	0.16	0.00	0.32	0.32
adrenal gland, adult, pool1	10081-102A9	3.64	3.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	39.66	1.07	2.50	2.50	3.22	0.71	2.86	0.00	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	58.66	11.13	0.46	0.93	1.62	0.00	3.71	0.00	3.71	0.23
amniotic membrane cells, donor2	12236-129G4	36.85	1.35	1.69	0.00	0.68	0.68	1.01	0.34	1.35	0.00
amniotic membrane cells, donor3	12237-129G5	58.33	3.54	1.18	0.88	4.42	0.29	3.24	0.59	2.06	0.88
amygdala - adult, donor10196	10167-103B5	4.74	0.00	0.00	1.19	1.19	0.00	1.19	0.00	1.19	1.19
amygdala, adult, donor10252	10151-102I7	6.08	0.41	1.82	0.61	0.00	0.61	0.20	0.61	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	6.13	0.32	0.32	2.58	1.61	0.65	0.97	0.00	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	179.28	2.42	8.53	7.77	1.27	6.62	2.42	4.20	0.76	1.78
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	18.09	0.88	0.00	0.00	3.97	4.41	0.22	1.32	0.22	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	53.11	1.67	3.34	1.00	1.34	0.33	2.00	0.00	1.67	1.67
aorta, adult, pool1	10052-101G7	17.65	1.77	1.77	0.39	3.53	0.59	1.96	0.78	0.59	1.37
appendix, adult	10189-103D9	23.68	0.78	0.78	1.16	0.39	1.55	0.00	0.78	0.00	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	1.03	0.00	0.00	0.34	1.03	0.00	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	13.59	0.00	0.00	1.36	1.36	0.00	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	23.18	1.45	0.43	2.90	0.43	0.87	0.72	1.01	0.14	0.00
b cell line:RPMI1788	10427-106D4	0.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	28.02	1.11	2.50	3.33	0.28	0.83	1.66	0.83	0.83	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	33.64	0.69	0.99	1.49	0.30	0.30	0.99	0.50	0.10	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	35.65	0.67	3.35	6.19	1.51	0.33	0.50	1.84	0.17	1.34
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	15.66	0.56	0.00	0.00	4.47	9.51	0.56	2.24	0.00	1.68
bladder, adult, pool1	10011-101C2	39.76	2.39	2.17	2.28	0.33	2.06	2.06	1.41	1.09	0.65
blood, adult, pool1	10053-101G8	4.43	0.00	0.00	0.00	2.21	4.43	0.00	4.43	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	24.83	0.00	1.71	0.00	0.00	0.86	3.43	0.86	0.00	0.00
bone marrow, adult	10192-103E3	25.64	0.67	2.02	0.00	0.00	4.05	2.70	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	5.13	1.03	0.00	0.00	0.00	0.00	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	4.57	0.33	2.00	0.33	0.00	0.33	0.22	0.11	0.22	0.11
brain, fetal, pool1	10085-102B4	2.67	0.00	0.00	2.67	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	92.50	1.65	0.33	2.64	1.32	2.64	1.65	0.66	0.99	6.94
breast carcinoma cell line:MDA-MB-453	10419-106C5	17.10	0.12	0.75	2.37	0.25	0.50	0.12	0.75	0.37	7.86
breast, adult, donor1	10080-102A8	12.63	0.00	1.26	2.53	0.00	0.63	0.00	0.63	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	22.74	2.41	3.30	1.14	0.25	0.13	0.76	0.64	0.89	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	38.34	1.24	1.24	0.93	2.78	1.86	0.62	0.62	0.93	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	24.86	0.00	1.61	1.38	1.38	0.69	0.46	0.69	0.46	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	59.07	2.42	4.60	2.66	0.73	0.97	1.21	1.21	1.45	1.45
carcinoid cell line:NCI-H1770	10703-109H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	64.32	0.66	1.31	1.97	0.88	1.20	0.88	0.55	0.00	3.06
carcinoid cell line:SK-PN-DW	10719-109I8	2.22	0.00	0.00	0.00	0.00	0.00	0.63	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	6.65	0.00	0.53	0.53	0.27	0.00	1.06	0.53	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	8.06	0.00	1.15	4.61	1.15	3.45	0.00	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	8.37	0.84	1.84	0.67	0.33	0.67	0.00	0.33	0.17	0.00
caudate nucleus, adult, donor10258	10379-105H1	3.82	0.00	3.82	0.00	2.29	0.00	0.00	0.00	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	12.82	2.20	4.39	4.76	5.49	0.73	1.46	1.83	1.10	0.73
cerebellum - adult, donor10196	10173-103C2	2.91	0.00	5.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	2.99	0.21	0.43	0.43	0.21	0.21	0.21	0.00	0.85	0.00
cerebellum, adult, pool1	10083-102B2	0.69	0.00	0.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	10.79	0.83	1.66	0.83	0.83	0.00	3.32	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	13.87	0.50	0.76	1.26	0.00	0.00	0.50	0.50	0.25	0.50
cerebrospinal fluid, donor2	10294-104G6	12.43	1.46	0.00	0.73	1.46	3.65	0.73	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	58.95	1.73	1.01	3.31	0.29	1.87	0.58	1.44	1.01	0.43
cervical cancer cell line:ME-180	10553-107I4	75.90	17.73	1.99	5.14	2.15	0.33	4.31	0.50	4.64	0.83
cervix, adult, pool1	10013-101C4	31.39	1.68	4.09	2.31	0.42	0.63	3.15	0.84	1.15	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	173.34	3.62	2.93	17.84	3.62	4.18	3.90	3.34	1.25	2.23
chondrosarcoma cell line:SW 1353	10700-109G7	11.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	143.79	4.47	2.98	1.86	3.73	11.93	0.87	6.09	2.61	0.12
choriocarcinoma cell line:SCH	10785-110H2	64.69	1.36	3.57	1.36	0.49	1.60	0.86	1.60	0.74	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	43.64	0.71	0.24	0.47	0.71	3.32	0.47	1.42	0.71	0.00
chorionic membrane cells, donor1	12238-129G6	77.78	13.11	1.14	0.28	3.99	0.85	1.99	1.14	3.42	0.85
chorionic membrane cells, donor2	12239-129G7	66.02	5.97	4.57	2.09	0.70	0.80	1.99	0.30	1.59	0.20
chorionic membrane cells, donor3	12240-129G8	142.32	14.84	1.10	2.75	4.40	2.20	4.95	0.55	8.24	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	14.60	0.38	0.38	0.58	1.73	1.92	0.19	0.38	0.58	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	27.03	1.27	0.63	0.21	2.11	0.42	0.21	1.27	0.63	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	23.11	0.00	1.03	0.26	1.54	0.26	0.51	0.26	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	35.31	1.21	0.48	0.48	1.45	0.73	0.00	0.24	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	24.43	0.00	0.20	0.61	2.24	0.81	0.00	0.41	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	36.22	0.59	1.18	0.00	2.36	1.47	0.00	0.29	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	24.50	2.87	0.52	0.00	1.56	1.30	0.26	0.52	0.00	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	86.40	0.69	2.06	1.14	4.34	3.66	0.69	0.69	0.69	1.14
clear cell carcinoma cell line:TEN	10636-108I6	66.11	2.26	6.07	1.91	3.47	1.74	1.21	1.21	0.52	0.00
colon carcinoma cell line:CACO-2	10513-107D9	48.69	0.73	6.22	1.28	1.65	0.37	0.37	0.37	0.18	1.46
colon carcinoma cell line:COLO-320	10420-106C6	28.51	0.00	0.00	0.76	0.00	0.38	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	17.85	0.00	2.38	0.00	0.00	1.19	1.19	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	30.20	1.53	3.06	1.29	0.47	0.82	0.47	0.59	0.59	0.94
colon, fetal, donor1	10070-101I7	24.72	1.85	4.33	0.62	1.24	0.00	1.24	0.00	0.62	1.24
common myeloid progenitor CMP, donor1	12130-128D6	55.00	4.58	0.00	0.00	0.00	13.75	0.00	22.92	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	25.92	0.85	0.00	1.70	0.42	4.67	1.27	4.25	1.27	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	8.45	0.75	0.00	0.15	0.15	1.81	0.00	1.21	0.30	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	11.42	0.42	0.14	0.28	0.28	2.40	0.00	0.85	0.28	0.00
corpus callosum, adult, pool1	10042-101F6	16.47	0.77	3.98	1.11	1.66	0.66	0.22	0.33	0.44	1.66
cruciate ligament, donor2	10295-104G7	39.71	4.86	2.43	0.81	3.24	3.24	0.81	0.81	0.81	2.43
diaphragm, fetal, donor1	10069-101I6	4.01	1.61	0.00	0.80	0.00	0.80	2.41	0.00	0.00	0.00
diencephalon, adult	10193-103E4	4.56	0.24	2.16	0.48	0.96	0.48	0.00	0.00	0.24	1.44
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	13.09	1.15	0.00	0.00	0.69	2.53	0.00	0.46	0.92	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	209.77	12.82	3.33	4.62	5.39	2.82	4.87	2.82	7.44	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	49.35	1.20	3.85	2.41	3.37	0.96	1.93	0.48	0.24	0.48
ductus deferens, adult	10196-103E7	59.30	1.99	5.48	1.00	0.00	0.50	1.50	0.50	2.99	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	5.76	0.00	2.88	0.00	1.44	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	32.37	0.74	1.47	1.47	0.74	0.00	0.74	0.74	0.74	0.00
dura mater, adult, donor1	10041-101F5	18.09	0.08	1.07	1.49	3.06	1.49	1.07	0.74	0.58	1.73
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	16.88	1.55	0.22	3.33	2.00	0.89	0.44	0.00	0.00	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	19.49	0.43	0.29	1.00	0.14	0.43	0.29	0.43	0.14	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	49.33	0.00	2.47	1.23	0.00	2.47	0.00	1.23	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	50.55	0.91	0.91	1.82	0.61	0.91	0.00	1.51	1.21	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	59.90	0.93	0.93	2.78	0.31	1.54	1.23	3.40	0.31	0.62
embryonic pancreas cell line:2C6	10603-108E9	56.48	2.63	1.31	2.63	0.00	1.31	0.00	2.63	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	108.27	3.02	12.07	4.02	2.01	1.34	1.34	1.68	1.68	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	68.87	2.72	3.62	3.44	0.54	2.54	3.26	0.91	1.27	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	36.83	3.54	1.77	0.96	0.00	0.00	1.29	0.16	2.09	1.13
epidermoid carcinoma cell line:A431	10426-106D3	26.57	4.00	4.34	0.56	0.67	0.11	2.56	0.00	1.11	1.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	59.61	7.37	4.84	1.54	3.19	1.21	1.54	0.88	2.64	0.55
epididymis, adult	10197-103E8	42.28	1.05	2.72	2.30	0.42	1.26	0.84	0.84	0.63	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	55.17	1.06	3.19	11.18	1.77	0.35	3.19	0.71	1.06	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	61.35	0.00	3.93	5.11	0.79	1.18	1.57	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	49.01	2.88	1.83	1.70	3.41	0.92	0.66	1.57	1.44	2.23
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	65.35	2.76	2.26	3.15	2.56	2.07	1.87	2.07	1.67	3.35
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	49.63	2.46	2.46	1.12	3.02	1.34	1.34	1.46	2.02	2.02
esophagus, adult, pool1	10015-101C6	26.44	2.12	2.65	1.70	0.11	0.64	1.06	0.42	1.17	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	87.29	7.64	2.76	5.26	0.50	0.38	9.64	0.50	2.88	0.50
eye - muscle inferior rectus, donor1	10272-104E2	2.41	0.00	0.00	2.41	2.41	0.00	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	4.21	0.00	0.00	0.00	0.00	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	10.32	0.00	1.15	1.15	3.44	0.00	1.15	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	7.29	1.46	1.46	0.00	5.83	5.83	2.91	0.00	1.46	5.83
eye, fetal, donor1	10054-101G9	24.41	1.02	2.29	1.27	0.25	0.76	1.02	0.25	0.76	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	21.93	0.51	1.03	1.03	0.90	1.41	0.38	0.26	0.26	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	15.19	0.47	0.71	0.00	3.32	1.42	0.00	0.24	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	2.44	0.19	1.22	0.19	0.09	0.56	0.28	0.09	0.00	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	87.37	12.91	6.61	3.60	7.51	1.20	2.10	0.60	6.91	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	97.29	1.46	2.93	4.75	1.83	2.83	1.19	2.01	0.64	0.46
gall bladder, adult	10198-103E9	31.14	1.21	4.35	1.93	1.21	0.97	0.97	0.48	0.72	1.93
gamma delta positive T cells, donor1	11937-126A2	47.78	3.22	1.07	0.00	1.07	7.52	0.54	3.76	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	13.45	1.12	0.00	0.00	0.00	4.48	0.00	1.87	1.12	2.24
gastric adenocarcinoma cell line:MKN1	10614-108G2	43.30	2.53	1.90	1.06	0.84	0.84	0.84	0.00	1.27	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	104.44	2.13	5.03	4.26	2.90	0.58	1.93	0.58	0.58	9.67
gastric cancer cell line:AZ521	10549-107H9	111.16	1.64	1.48	18.20	3.93	0.82	2.13	0.49	1.31	0.98
gastric cancer cell line:GSS	10560-108A2	69.56	0.00	1.83	1.83	6.41	1.83	0.92	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	5.71	0.00	0.23	0.00	0.91	0.00	0.00	0.00	0.00	1.14
giant cell carcinoma cell line:LU65	10487-107B1	22.03	1.49	0.46	1.26	2.07	3.44	0.11	2.52	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	48.57	0.70	0.28	1.68	0.70	2.10	0.70	1.54	0.42	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	85.80	6.24	5.24	1.50	2.00	1.50	1.75	1.00	2.49	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	15.62	0.21	1.16	1.06	0.32	0.42	0.42	0.11	0.00	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	14.04	0.00	1.12	0.56	0.70	0.14	0.70	0.14	0.28	0.00
glioblastoma cell line:T98G	10485-107A8	38.30	0.88	2.54	1.88	0.77	0.77	0.55	0.77	0.22	1.55
glioma cell line:GI-1	10413-106B8	57.99	0.88	2.64	3.81	0.29	2.64	1.76	0.59	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	2.92	0.73	2.19	0.00	3.64	0.73	0.73	1.46	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	8.30	0.73	1.46	1.22	0.49	0.24	0.00	0.00	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	1.37	1.37	2.74	0.00	0.00	0.00	0.00	1.37	0.00	2.74
globus pallidus, newborn, donor10223	10364-105F4	10.13	0.53	0.53	1.60	2.13	1.07	0.00	1.07	0.00	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	34.26	0.00	0.00	0.00	7.34	19.58	0.00	12.24	7.34	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	0.00	0.00	0.00	0.00	5.23	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	30.72	0.32	1.92	0.64	0.32	0.96	2.56	0.64	0.64	1.28
hIPS +CCl2, biol_rep1	14383-156B9	104.68	0.92	11.94	3.21	1.38	0.46	0.00	0.46	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	115.69	0.00	8.69	3.20	0.91	0.00	1.37	0.00	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	84.38	1.29	9.66	0.64	0.00	2.58	1.29	0.00	1.93	0.00
hIPS, biol_rep1	14380-156B6	145.17	0.00	4.31	0.00	1.44	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	108.37	1.37	8.92	0.00	0.00	0.00	2.74	0.00	1.37	0.69
hIPS, biol_rep3	14382-156B8	6.62	0.00	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	0.57	0.00	0.00	0.00	0.00	1.15	0.00	0.00	0.29	0.00
heart - mitral valve, adult	10205-103F7	25.11	0.60	0.90	0.90	3.89	1.20	0.30	1.20	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	6.01	0.26	1.05	0.26	0.00	0.00	0.26	0.00	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	61.62	0.83	0.83	5.83	1.67	3.33	2.50	1.67	5.83	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	24.08	2.65	1.22	1.43	0.82	0.82	0.20	0.61	1.22	0.00
heart, adult, diseased, donor1	10051-101G6	5.54	0.00	0.43	0.43	0.00	1.70	0.43	0.43	0.00	0.00
heart, adult, pool1	10016-101C7	11.73	0.23	0.46	0.23	0.46	0.92	0.23	0.23	0.46	0.00
heart, fetal, pool1	10046-101G1	27.00	0.92	0.72	1.95	0.21	0.92	0.41	0.51	0.31	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	19.13	0.62	2.16	2.16	0.00	0.62	0.93	1.54	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	65.40	0.00	0.00	3.57	1.19	2.38	1.19	0.00	0.00	10.70
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	22.10	0.55	2.32	0.44	0.55	0.44	0.11	0.11	0.00	5.08
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	22.58	0.24	2.67	0.36	0.36	0.61	0.12	0.73	0.12	6.31
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	22.33	0.40	2.83	0.71	0.71	1.21	0.61	0.61	0.40	5.25
hepatoma cell line:Li-7	10484-107A7	62.95	0.89	5.67	5.12	2.89	1.00	0.56	1.22	0.33	3.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	0.00	0.00	0.00	1.21	1.21	0.00	0.10	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	5.68	0.00	0.00	0.00	0.00	0.00	0.95	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	6.74	0.20	1.63	1.22	0.00	0.41	0.00	0.20	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	4.48	0.00	0.50	0.00	0.00	0.00	0.00	0.00	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	3.52	0.00	0.35	1.41	1.76	0.00	0.35	0.35	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	178.83	0.61	19.53	2.44	6.71	1.83	1.83	1.83	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	108.58	1.37	8.44	1.57	2.75	0.98	0.98	0.59	0.39	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	127.96	1.02	12.19	2.54	3.30	0.76	0.76	0.76	2.03	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	128.00	1.69	7.33	10.71	11.84	0.56	0.56	1.13	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	104.83	1.81	11.10	13.94	6.20	0.26	0.52	0.26	0.77	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	180.31	2.66	12.53	15.18	6.45	0.00	3.80	0.38	0.38	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	59.85	1.75	7.88	8.76	2.63	0.00	1.46	0.00	0.88	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	57.52	1.08	5.82	6.46	4.52	0.86	2.15	0.43	0.43	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	54.22	1.25	5.84	5.42	5.42	0.42	0.83	0.00	0.83	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	62.04	4.03	2.84	7.10	3.32	0.47	2.37	0.24	0.95	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	38.89	1.45	5.30	4.98	2.57	0.48	1.45	0.32	0.64	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	48.48	1.35	2.02	8.75	0.67	0.00	1.35	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	94.05	1.88	11.74	1.10	1.72	0.47	0.63	1.10	0.63	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	94.82	0.98	10.32	2.46	1.47	0.49	0.00	0.49	0.00	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	144.88	2.62	19.20	4.36	2.62	0.87	0.87	0.87	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	137.65	1.15	17.37	9.35	5.15	0.57	1.72	0.00	1.15	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	124.28	0.87	12.21	5.67	3.92	0.00	1.31	0.00	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	149.43	1.50	11.99	9.50	8.00	0.00	1.50	0.00	0.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	74.98	0.94	6.41	5.27	6.97	1.51	2.26	0.75	0.57	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	68.21	1.36	6.82	5.91	8.64	2.27	3.18	0.00	0.91	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	80.81	2.82	6.26	3.76	9.71	1.57	2.51	0.63	0.94	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	76.26	4.41	2.61	4.57	3.27	0.49	4.08	0.33	1.14	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	74.03	1.74	1.74	2.90	2.90	0.87	3.77	0.00	1.74	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	75.63	3.89	3.29	4.78	3.59	0.30	3.89	0.30	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	106.23	1.29	14.04	4.25	2.03	0.37	0.37	0.18	0.74	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	98.99	0.57	11.41	3.42	3.71	1.43	0.57	0.00	0.86	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	173.12	1.63	18.37	7.76	3.27	0.00	0.82	1.22	1.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	94.71	2.82	11.97	4.93	2.46	0.00	1.76	0.00	1.41	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	86.15	1.58	8.24	5.38	2.22	0.32	0.00	0.63	0.32	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	134.36	2.42	7.26	6.66	2.72	0.61	1.21	0.00	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	61.54	1.55	5.17	4.65	5.17	0.00	1.03	0.00	1.55	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	58.45	0.66	2.66	3.32	3.32	0.66	1.33	0.66	0.00	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	75.93	1.54	4.62	2.31	2.82	0.26	2.82	0.00	0.51	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	48.32	3.07	3.58	1.79	2.30	0.00	3.07	0.26	0.77	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	53.76	1.51	3.03	3.79	2.27	0.76	2.27	0.00	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	47.05	0.34	3.70	5.38	0.34	0.67	4.37	1.34	1.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	124.13	1.21	16.18	3.38	2.66	0.48	0.72	0.00	0.72	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	137.71	0.89	11.14	3.12	2.67	1.34	0.45	0.00	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	131.22	1.46	10.73	3.41	1.46	0.98	0.49	0.49	0.49	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	118.58	0.92	12.53	8.86	3.06	1.22	0.61	0.31	0.31	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	377.38	9.76	61.81	22.77	3.25	0.00	0.00	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	159.51	1.99	15.89	15.89	3.97	0.99	1.65	0.66	0.33	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	91.40	1.64	5.47	5.47	5.47	0.55	1.09	1.09	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	73.10	2.17	6.51	8.32	5.43	0.72	1.81	0.00	1.09	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	84.70	1.78	5.69	6.41	3.56	0.71	1.42	0.00	1.42	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	64.44	2.39	1.19	4.77	2.39	0.00	0.00	1.19	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	90.60	2.84	6.64	10.02	4.33	0.27	3.25	0.14	1.08	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	50.11	2.69	2.96	4.31	4.58	0.00	2.42	0.00	1.35	0.54
immature langerhans cells, donor1	11904-125F5	75.07	2.42	2.18	1.45	5.33	3.15	1.70	2.66	1.70	4.12
immature langerhans cells, donor2	11905-125F6	72.08	2.38	5.54	7.13	16.63	1.58	1.58	1.58	5.54	11.88
insula, adult, pool1	10039-101F3	2.18	0.38	1.89	0.19	0.19	0.57	0.09	0.19	0.09	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	36.74	3.58	3.25	2.60	1.30	0.33	1.95	0.33	1.63	0.00
kidney, adult, pool1	10017-101C8	30.04	0.60	2.10	1.30	0.10	0.50	0.90	0.60	0.20	0.20
kidney, fetal, pool1	10045-101F9	67.13	1.77	2.83	1.91	0.28	0.78	0.99	0.21	0.71	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	44.59	1.85	1.56	3.27	0.28	2.70	0.71	1.14	0.43	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	32.49	1.94	1.52	2.35	1.38	0.69	0.55	1.11	0.69	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	91.57	4.59	2.20	2.94	3.49	2.20	2.94	1.65	1.83	0.37
left atrium, adult, donor1	10079-102A7	0.54	0.00	0.00	0.00	0.00	1.09	0.54	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	5.56	0.51	0.00	0.51	0.51	0.51	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	23.26	0.82	2.46	4.10	3.56	0.55	1.92	0.55	0.00	2.46
leiomyoma cell line:10964C	10569-108B2	8.98	0.00	3.23	1.08	0.00	0.00	0.36	0.36	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	11.41	0.54	1.63	2.17	1.09	1.63	1.09	0.00	0.54	1.09
leiomyoma cell line:15425	10571-108B4	11.17	0.49	3.16	1.70	0.00	0.00	0.49	0.00	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	63.49	6.35	0.00	6.35	0.00	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	14.64	0.00	0.00	1.05	2.09	1.05	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	92.79	1.18	0.47	2.36	12.16	3.07	0.94	1.42	0.35	3.31
liposarcoma cell line:KMLS-1	10782-110G8	16.25	0.78	2.81	0.78	2.81	0.47	0.31	0.47	0.31	0.16
liposarcoma cell line:SW 872	10726-110A6	21.44	0.12	1.22	4.02	1.71	0.61	0.12	0.61	0.00	0.12
liver, adult, pool1	10018-101C9	27.55	0.49	2.27	0.49	0.65	1.46	0.16	0.32	0.00	4.21
liver, fetal, pool1	10086-102B5	9.41	0.00	0.94	0.00	0.94	0.00	0.00	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	8.60	0.29	1.46	0.44	0.73	0.58	0.29	0.73	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	8.12	0.18	2.40	2.03	0.18	0.74	0.18	0.37	0.74	0.00
locus coeruleus, adult, donor10258	10375-105G6	4.23	0.56	1.13	0.28	0.85	0.00	0.00	0.00	0.28	1.41
locus coeruleus, newborn, donor10223	10362-105F2	12.62	1.68	7.57	3.36	1.26	2.10	0.42	1.26	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	54.11	0.97	2.35	1.66	0.83	1.11	0.83	0.97	0.14	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	55.84	2.76	7.58	3.45	0.00	1.38	0.69	0.69	0.69	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	51.94	0.79	1.19	4.22	0.26	0.79	1.19	0.40	0.13	0.40
lung, adult, pool1	10019-101D1	34.49	1.77	2.48	1.77	0.71	2.84	0.83	1.30	0.59	0.35
lung, fetal, donor1	10068-101I5	56.51	2.28	2.00	1.43	0.86	1.14	0.86	0.29	1.14	0.29
lung, right lower lobe, adult, donor1	10075-102A3	14.66	1.37	2.29	2.75	0.00	1.37	0.00	1.83	0.46	0.46
lymph node, adult, donor1	10077-102A5	8.52	0.47	0.00	0.00	0.47	0.00	0.00	0.00	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	4.60	0.00	0.00	0.00	0.44	0.88	0.00	0.00	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	5.28	0.15	0.15	0.00	0.00	0.60	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	159.71	12.74	0.85	5.95	1.70	0.85	4.25	3.40	1.70	2.55
mature adipocyte, donor1	12231-129F8	5.77	2.22	1.33	1.33	1.78	2.22	0.00	0.89	0.00	0.00
mature adipocyte, donor2	12232-129F9	7.26	0.21	0.62	1.04	0.42	2.91	0.42	1.04	0.42	0.21
mature adipocyte, donor3	12233-129G1	10.19	0.00	0.47	1.42	0.95	1.90	1.19	0.95	0.24	0.24
mature adipocyte, donor4	12234-129G2	6.58	0.79	1.84	1.05	1.05	2.90	0.00	0.53	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	98.40	2.86	2.86	2.62	1.19	2.62	1.43	0.24	0.00	2.86
medial frontal gyrus - adult, donor10196	10170-103B8	2.26	0.00	1.13	0.00	0.00	0.00	0.00	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	4.78	0.37	0.18	0.37	0.00	0.74	0.00	0.37	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	1.59	0.00	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	8.96	0.85	1.71	2.56	0.85	0.85	0.00	0.00	1.71	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	1.69	0.00	1.69	0.00	0.00	0.17	0.17	0.17	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	3.82	0.42	0.21	0.00	0.00	0.21	0.00	0.21	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	3.59	0.36	1.44	1.08	2.15	0.36	0.36	0.36	0.00	0.72
medulla oblongata - adult, donor10196	10174-103C3	11.03	0.65	0.65	1.30	1.95	1.30	0.00	0.65	0.65	1.30
medulla oblongata, adult, donor10252	10155-103A2	10.22	0.93	1.86	1.55	0.46	0.31	0.62	0.62	0.62	0.00
medulla oblongata, adult, pool1	10038-101F2	8.08	0.73	1.39	0.82	0.41	1.06	0.16	0.24	0.08	0.73
medulla oblongata, newborn, donor10223	10361-105F1	12.50	1.74	5.55	4.51	1.39	0.35	0.00	1.04	0.69	0.69
medulloblastoma cell line:D283 Med	10838-111E1	75.06	1.55	0.22	4.65	0.22	0.66	0.44	0.44	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	26.66	0.49	0.73	1.47	1.83	0.24	0.37	0.12	0.37	0.37
melanoma cell line:COLO 679	10514-107E1	43.27	2.16	1.15	3.45	0.57	0.72	0.72	1.29	1.15	0.00
melanoma cell line:G-361	10465-106H6	71.39	7.60	2.44	4.89	0.54	0.81	3.26	3.80	2.44	0.27
meningioma cell line:HKBMM	10691-109F7	43.60	0.18	1.09	1.63	0.18	0.90	0.00	0.54	0.36	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	4.41	0.00	0.00	0.00	0.00	0.88	0.88	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	18.66	0.26	0.00	1.81	0.26	0.78	1.30	0.52	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	42.81	1.53	1.99	4.45	1.69	1.38	1.53	0.61	0.31	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	50.90	0.91	4.36	3.27	2.73	3.27	4.54	2.73	0.55	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	36.03	0.83	2.07	4.14	4.14	0.83	2.48	0.41	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	43.97	2.39	6.60	5.20	2.11	1.83	2.25	1.83	0.98	1.69
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	18.68	0.96	1.73	1.73	1.93	1.73	2.31	0.77	0.39	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	21.52	1.39	4.86	2.78	4.16	0.00	3.47	0.00	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	89.59	3.60	7.38	8.75	2.57	5.15	3.95	3.26	1.03	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	53.94	2.65	4.83	6.10	1.96	2.19	3.45	0.92	0.69	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	52.39	2.12	1.59	5.44	2.52	2.52	2.92	0.93	0.27	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	68.60	2.70	2.70	4.86	2.03	1.62	2.97	1.08	0.68	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	37.56	0.71	2.28	3.41	1.28	1.00	1.71	0.71	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	106.05	3.29	2.31	9.55	2.96	0.99	2.63	3.62	3.29	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	43.73	1.11	1.66	2.63	1.38	1.38	0.55	0.42	0.55	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	37.35	1.75	0.70	3.14	1.75	0.35	2.09	1.40	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	29.60	0.61	1.02	0.82	1.22	1.22	1.22	0.20	0.61	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	43.13	0.72	0.72	2.52	2.88	1.08	0.72	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	35.38	0.52	1.66	1.97	1.03	1.24	1.03	0.72	0.31	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	21.20	1.14	1.37	2.51	0.91	0.46	1.37	0.00	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	43.63	1.26	0.42	1.26	1.68	1.26	0.00	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	48.87	2.24	1.94	2.84	5.08	1.64	1.20	1.79	0.30	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	58.30	0.53	1.49	6.13	2.01	1.84	2.28	1.58	0.26	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	93.88	1.10	2.21	5.52	2.58	2.58	0.74	1.47	0.37	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	32.91	1.14	2.29	2.86	0.86	0.86	1.14	0.57	0.57	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	26.94	2.11	0.42	2.95	1.26	0.00	8.84	0.42	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	20.09	1.37	2.74	0.46	0.91	1.37	2.28	0.46	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	25.07	2.05	2.05	3.07	0.26	1.02	2.30	0.77	0.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	23.82	2.36	3.93	1.31	0.79	0.26	2.88	0.26	1.31	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	21.57	2.16	4.31	4.93	0.62	1.54	3.08	0.31	1.23	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	24.01	1.18	6.12	4.00	0.47	0.94	2.82	0.24	0.24	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	23.69	0.68	2.37	4.06	1.69	2.03	3.05	0.34	1.35	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	23.58	0.79	5.50	3.93	0.39	1.57	1.96	0.00	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.46	1.39	1.85	3.24	0.46	0.46	2.32	0.00	1.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	48.30	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	28.55	3.17	5.19	6.06	0.00	1.15	3.17	0.58	2.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	30.12	2.68	4.91	3.57	0.67	0.67	2.90	0.67	0.22	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	31.25	1.92	4.57	4.33	0.24	1.20	1.44	0.24	0.72	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	22.00	3.67	2.20	0.73	0.73	1.47	0.73	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	22.82	0.67	4.36	1.68	0.67	1.68	2.69	0.34	0.00	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	20.88	0.82	3.28	2.46	0.00	0.41	1.64	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	29.21	1.72	2.58	3.87	0.43	0.00	3.01	0.86	1.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	0.00	5.47	5.47	0.00	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	0.00	0.00	5.16	0.00	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	19.81	0.32	1.62	4.22	0.00	1.30	1.30	0.32	0.97	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	1.45	1.45	1.45	1.45	0.00	0.00	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	16.53	1.07	0.53	1.07	1.07	0.00	1.07	0.53	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	5.72	0.82	1.64	3.27	0.00	0.00	1.64	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	13.99	1.94	1.94	1.17	0.00	0.78	1.55	0.00	1.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	0.00	2.10	8.39	0.00	4.20	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	10.93	0.99	0.00	2.98	2.98	0.99	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	0.00	0.00	4.77	0.00	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	11.27	0.00	1.19	6.52	0.00	0.59	1.78	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	8.53	2.44	0.00	0.00	0.00	0.00	0.00	1.22	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	10.77	0.63	3.17	1.27	0.00	0.63	1.27	0.63	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	4.48	0.34	1.38	0.00	0.00	0.00	1.03	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	0.00	2.15	0.00	0.00	0.00	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	0.00	3.44	0.00	0.00	0.00	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	11.41	0.00	2.04	0.00	0.00	0.00	0.00	0.41	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.15	0.00	3.97	0.00	0.79	1.59	0.00	0.00	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	3.54	1.77	2.36	0.00	0.00	1.18	0.00	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	2.18	0.31	2.81	0.94	0.62	1.25	0.00	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	5.35	0.00	1.34	1.34	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	2.37	0.00	1.18	1.18	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	0.00	0.00	0.00	0.00	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	4.82	0.69	0.00	0.00	0.00	0.00	0.69	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	0.49	0.99	0.49	0.00	0.00	0.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	2.24	0.00	0.00	0.00	0.00	1.12	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1.91	1.27	0.00	0.00	0.00	0.64	0.00	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	2.01	0.00	0.00	0.40	0.00	0.81	0.00	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	0.00	0.00	0.00	0.00	0.00	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	8.50	0.61	2.43	0.61	0.00	2.43	0.61	1.21	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	4.94	0.00	0.00	0.82	0.00	2.47	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	3.77	0.79	2.58	0.60	0.00	0.40	0.20	0.20	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	1.62	0.00	0.97	0.00	0.00	0.97	0.00	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	4.07	1.02	0.00	0.00	0.00	1.02	3.06	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	10.06	0.77	0.00	0.00	0.00	0.00	0.77	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	31.42	0.71	0.24	1.18	0.94	0.94	0.94	0.94	0.47	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	21.55	0.70	3.71	3.24	0.70	0.00	2.32	0.00	0.23	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	68.38	0.00	0.00	8.55	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	37.50	1.44	3.29	1.54	2.36	0.62	0.82	0.41	0.31	0.82
mesothelioma cell line:Mero-25	10850-111F4	75.58	2.04	2.27	6.35	2.27	0.45	2.50	1.82	1.13	0.23
mesothelioma cell line:Mero-41	10851-111F5	36.18	0.73	1.71	0.98	1.47	0.49	0.49	0.98	0.49	0.49
mesothelioma cell line:Mero-48a	10852-111F6	21.92	0.00	1.33	0.66	0.22	0.00	0.89	0.22	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	104.33	5.26	2.89	4.99	3.68	0.79	2.89	0.79	1.58	0.53
mesothelioma cell line:Mero-83	10854-111F8	21.79	0.00	1.87	1.19	1.19	0.85	0.68	0.68	0.17	0.17
mesothelioma cell line:Mero-84	10855-111F9	29.07	1.01	1.52	1.77	0.25	0.00	1.77	0.00	0.25	0.25
mesothelioma cell line:Mero-95	10856-111G1	52.17	1.45	3.93	3.52	0.62	0.62	1.86	0.83	0.83	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	30.98	0.83	1.33	1.99	1.82	0.33	0.17	0.66	0.99	0.00
mesothelioma cell line:NCI-H226	10846-111E9	32.40	0.36	4.34	3.44	1.09	0.36	1.63	0.18	0.54	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	37.07	0.85	5.12	6.15	1.37	0.00	1.54	0.17	0.34	0.17
mesothelioma cell line:NCI-H28	10845-111E8	75.32	1.53	0.76	2.29	1.02	0.00	1.27	0.25	0.25	1.53
mesothelioma cell line:No36	10857-111G2	23.81	0.00	0.98	1.63	1.30	0.33	0.98	0.00	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	30.08	1.08	1.35	2.98	1.35	0.54	0.81	0.81	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	92.89	2.11	0.38	0.77	0.77	3.65	0.38	2.11	0.58	0.00
migratory langerhans cells, donor2	11902-125F3	99.52	1.47	1.22	0.73	1.59	2.69	0.24	0.85	1.47	0.49
migratory langerhans cells, donor3	11903-125F4	106.07	1.62	0.90	0.36	1.26	4.85	0.36	1.44	0.72	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	42.12	1.31	0.65	0.33	0.33	0.00	0.65	0.00	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	31.37	0.85	1.27	0.85	8.48	1.70	0.64	1.48	0.21	2.33
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	82.47	2.07	1.61	1.61	2.07	1.15	1.84	1.15	0.69	3.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	2.85	0.57	0.00	0.00	0.95	1.14	0.19	0.38	0.00	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	24.76	0.00	0.37	0.55	2.03	9.79	0.92	4.80	0.37	0.18
myeloma cell line:PCM6	10474-106I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	24.35	0.00	0.51	0.51	0.00	0.51	0.51	0.51	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	70.41	4.32	8.04	5.49	11.18	2.55	2.75	2.75	1.57	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	123.01	18.16	1.89	2.01	0.45	2.01	3.57	2.01	6.24	2.90
nasal epithelial cells, donor1, tech_rep2	12226-129F3	115.02	19.49	1.84	3.60	0.74	1.32	4.41	1.62	5.74	2.21
nasal epithelial cells, donor2	12227-129F4	83.90	5.52	2.21	4.97	0.00	1.10	1.10	0.00	2.76	0.55
neuroblastoma cell line:CHP-134	10508-107D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	16.09	0.37	0.00	0.56	0.19	0.37	0.37	0.37	0.19	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	159.64	1.90	2.32	4.64	5.90	3.59	1.27	2.11	1.05	0.63
neuroblastoma cell line:NH-12	10555-107I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	84.45	3.32	1.66	1.90	2.14	4.27	2.37	1.66	2.14	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	18.06	0.63	3.01	1.90	1.90	0.63	0.95	0.79	0.32	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	33.61	0.60	2.42	1.01	0.40	3.42	0.60	2.42	0.81	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	18.44	0.00	1.91	0.00	0.00	1.27	1.27	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	22.62	1.33	2.66	2.13	0.80	0.27	0.80	0.53	0.00	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	64.10	0.34	0.68	0.00	5.75	6.60	0.17	1.01	0.51	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	28.02	1.60	0.00	0.80	0.00	0.80	0.00	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	114.78	3.85	5.13	7.05	3.21	2.24	7.05	1.92	1.60	7.69
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	14.71	0.26	3.68	1.58	0.53	0.53	1.05	0.26	0.00	0.26
nucleus accumbens, adult, pool1	10037-101F1	4.50	0.37	1.50	0.47	0.00	0.00	0.00	0.47	0.19	0.37
occipital cortex - adult, donor10196	10172-103C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	8.32	0.27	1.07	0.81	0.27	0.27	0.54	0.81	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	5.46	0.00	0.36	1.46	1.46	0.00	0.36	0.00	0.73	1.09
occipital lobe, adult, donor1	10076-102A4	1.84	0.26	0.52	0.26	0.00	0.26	0.00	0.00	0.00	0.79
occipital lobe, fetal, donor1	10073-102A1	0.86	0.00	0.00	1.29	1.29	0.00	1.72	0.00	0.00	0.43
occipital pole, adult, pool1	10036-101E9	2.44	0.16	0.87	0.16	0.16	0.16	0.47	0.08	0.08	0.39
olfactory region, adult	10195-103E6	3.63	0.38	1.91	0.00	0.38	0.38	0.00	0.19	0.38	0.38
optic nerve, donor1	10277-104E7	16.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	84.06	7.75	5.47	4.78	1.03	1.59	2.85	0.91	2.16	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	87.79	6.87	2.47	3.85	2.06	1.10	0.82	0.96	1.92	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	39.28	5.76	2.54	2.03	0.51	0.17	1.86	0.00	1.69	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	55.10	1.73	1.85	2.19	1.39	0.81	1.85	0.46	0.46	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	28.22	0.88	0.29	2.35	0.59	0.59	1.18	0.59	0.00	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	111.19	0.00	2.80	4.67	4.67	2.80	0.93	1.87	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	4.45	0.21	0.64	0.00	0.00	0.64	0.00	0.42	0.00	0.85
ovary, adult, pool1	10020-101D2	21.40	1.31	1.83	1.57	0.26	0.61	0.96	0.09	0.61	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	28.78	0.00	0.37	0.00	1.65	2.93	0.37	0.92	0.37	0.37
pancreas, adult, donor1	10049-101G4	16.93	0.00	1.88	0.00	0.00	0.00	3.76	0.00	0.00	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	38.02	1.40	1.12	0.00	0.28	1.12	0.56	0.00	0.84	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	76.15	3.58	1.70	6.30	1.70	1.02	1.53	0.51	3.41	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	34.61	1.82	0.33	1.16	1.32	0.00	0.17	0.17	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	2.56	0.18	1.10	0.09	0.18	0.00	0.09	0.18	0.00	0.64
parietal cortex, adult, donor10258	10373-105G4	13.21	0.00	1.47	0.00	1.47	0.00	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	2.82	0.00	0.00	0.00	0.00	0.00	0.94	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	5.13	0.86	1.71	0.29	0.00	0.29	0.00	0.57	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	2.38	0.09	1.15	0.26	0.35	0.18	0.00	0.09	0.18	0.35
parietal lobe, fetal, donor1	10072-101I9	4.85	0.97	0.97	1.94	0.97	0.00	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	5.23	0.75	1.87	1.50	1.50	0.37	0.75	0.75	0.00	0.75
parotid gland, adult	10199-103F1	8.02	1.23	1.85	4.32	0.00	2.47	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	11.82	0.00	0.54	1.07	0.00	0.54	1.07	0.54	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	10.41	0.00	0.93	0.19	1.49	0.37	0.19	0.00	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	47.21	1.89	2.77	3.35	2.48	0.44	1.02	0.73	1.17	1.17
pineal gland - adult, donor10196	10179-103C8	5.16	0.65	0.00	0.00	1.29	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	2.37	0.00	0.00	0.59	0.00	0.00	0.00	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	2.51	1.25	0.63	0.00	0.00	0.00	0.00	0.00	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	15.18	0.00	2.02	2.02	1.01	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	5.73	0.52	1.04	1.04	0.00	0.52	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	0.00	0.00	0.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	53.21	5.05	1.40	1.08	0.54	1.29	1.83	1.18	2.15	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	2.25	0.13	0.00	0.00	0.40	0.53	0.00	0.26	0.26	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	47.47	0.47	5.60	2.18	1.09	1.09	0.47	0.62	0.47	0.62
pons, adult, pool1	10033-101E6	3.53	0.09	0.52	0.09	0.17	0.26	0.17	0.43	0.17	0.09
postcentral gyrus, adult, pool1	10032-101E5	2.09	0.26	1.22	0.26	0.00	0.52	0.17	0.17	0.00	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	52.28	2.09	0.00	0.00	2.09	12.55	4.18	8.37	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	55.06	1.02	4.08	3.20	1.89	3.93	0.29	1.46	1.17	0.29
prostate cancer cell line:PC-3	10439-106E7	36.48	0.91	3.63	4.90	2.54	1.45	0.36	0.73	0.54	1.27
prostate, adult, pool1	10022-101D4	36.37	2.54	2.54	2.81	0.36	0.73	1.00	0.45	1.27	1.27
putamen, adult, donor10196	10176-103C5	3.54	0.00	2.12	0.47	0.00	0.47	0.00	0.24	0.24	0.24
putamen, adult, donor10252	10152-102I8	1.96	0.00	1.96	0.00	0.00	0.00	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	41.53	0.00	5.46	1.09	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	2.42	0.24	0.97	0.00	0.00	0.24	0.00	0.00	0.00	0.24
putamen, newborn, donor10223	10365-105F5	6.00	1.50	1.50	1.50	0.00	0.00	0.75	0.75	0.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	40.73	1.16	0.87	0.29	3.20	0.87	0.58	0.00	0.87	0.00
rectum, fetal, donor1	10067-101I4	30.60	1.39	1.39	0.00	1.39	0.00	8.35	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	25.86	0.00	3.18	0.21	0.85	0.21	0.42	0.21	0.42	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	57.58	0.00	1.66	0.83	1.24	2.90	0.41	2.07	0.83	2.49
retina, adult, pool1	10030-101E3	16.60	1.19	1.99	1.49	0.40	1.69	0.80	1.09	0.40	0.20
retinoblastoma cell line:Y79	10475-106I7	25.20	0.52	0.00	0.26	1.30	1.30	0.78	0.26	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	28.03	0.74	3.81	2.21	0.25	0.25	0.61	0.12	0.25	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	68.89	2.25	1.69	2.81	0.56	0.28	4.50	0.00	0.84	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	33.35	0.76	0.00	3.03	0.00	0.76	5.30	0.00	0.76	1.52
salivary acinar cells, donor1	11771-123I7	42.41	6.80	1.13	2.27	0.16	0.00	4.69	0.32	1.13	0.32
salivary acinar cells, donor2	11772-123I8	43.10	4.68	2.75	4.82	0.41	0.14	4.82	0.14	1.93	0.28
salivary acinar cells, donor3	11773-123I9	47.67	4.63	0.66	3.31	2.65	0.00	8.61	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	21.16	1.72	1.72	4.58	0.57	1.72	1.72	0.00	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	39.54	1.52	4.81	4.22	1.18	3.46	1.60	1.85	1.10	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	31.62	1.41	4.11	2.82	1.18	3.64	0.59	2.47	0.71	0.12
seminal vesicle, adult	10201-103F3	33.33	2.12	4.76	1.06	0.00	0.00	0.53	0.00	1.59	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	79.68	1.70	1.46	1.94	1.94	1.21	1.70	0.49	1.46	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	64.67	1.01	0.50	2.26	1.26	2.01	0.75	1.26	0.50	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	64.23	0.00	2.01	0.00	1.00	0.00	2.01	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	84.76	1.61	3.36	2.42	0.94	0.27	0.27	0.00	0.67	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	59.02	7.07	6.96	2.87	0.33	0.55	2.10	1.11	2.98	2.76
signet ring carcinoma cell line:NUGC-4	10483-107A6	35.35	1.03	4.52	0.77	1.03	0.13	0.13	0.13	0.77	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	7.09	0.00	0.00	1.42	0.71	0.71	0.00	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	21.83	1.56	0.48	1.32	0.00	2.52	0.96	0.84	0.24	0.36
skeletal muscle, fetal, donor1	10066-101I3	6.03	1.01	1.01	0.00	0.00	0.00	2.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	27.14	0.00	0.00	0.00	0.00	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	16.41	1.89	0.00	2.52	0.00	1.26	6.31	0.63	3.16	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	1.33	0.00	0.00	0.00	0.00	0.33	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	213.39	4.10	1.89	4.73	10.72	2.52	5.04	2.21	0.63	9.46
small cell lung carcinoma cell line:DMS 144	10841-111E4	60.91	0.77	0.77	3.47	3.66	1.93	1.54	0.77	0.39	1.93
small cell lung carcinoma cell line:LK-2	10541-107H1	109.28	1.98	1.48	8.74	4.12	1.65	1.65	1.98	1.15	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	23.97	0.16	0.00	0.16	0.97	0.80	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	76.92	1.53	0.65	3.27	2.40	0.87	0.65	0.44	0.22	0.87
small intestine, adult, pool1	10024-101D6	22.69	1.43	2.99	1.79	0.12	0.48	0.24	0.24	0.60	0.24
small intestine, fetal, donor1	10064-101I1	17.44	1.47	2.70	1.23	1.23	0.49	0.74	0.25	0.00	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	7.69	1.03	0.00	0.00	0.00	0.00	0.51	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	13.70	1.29	1.81	1.29	0.00	0.52	1.29	0.52	0.78	0.52
somatostatinoma cell line:QGP-1	10781-110G7	65.67	2.14	0.27	1.88	4.02	3.48	0.54	0.80	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	5.28	0.69	0.92	0.69	0.46	0.23	0.46	0.69	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	7.89	0.39	2.37	0.79	0.00	1.58	0.00	0.00	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	8.30	1.38	2.08	0.69	2.08	0.00	0.00	0.69	0.69	1.38
spinal cord, fetal, donor1	10056-101H2	12.81	0.00	2.44	1.22	0.00	1.22	0.61	0.00	0.00	1.83
spinal cord, newborn, donor10223	10359-105E8	11.48	0.92	5.51	1.84	0.92	0.46	1.38	0.46	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	37.19	1.05	1.94	2.84	1.05	0.15	1.94	1.05	0.60	0.00
spleen, adult, pool1	10025-101D7	21.26	2.42	2.53	0.77	0.00	1.65	0.66	0.88	0.77	0.00
spleen, fetal, pool1	10044-101F8	31.15	1.59	2.94	1.51	0.24	2.30	1.51	1.67	0.72	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	1.24	0.31	0.00	0.00	0.10	1.45	0.00	0.72	0.10	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	76.90	6.08	2.66	4.75	3.99	1.33	1.90	0.95	1.33	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	71.99	2.80	1.40	2.80	2.10	0.70	1.40	0.00	1.05	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	54.73	1.56	1.95	2.35	4.30	0.78	1.95	0.00	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	50.20	1.35	5.07	5.52	2.48	3.04	0.45	2.03	0.34	1.13
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	44.48	3.39	4.66	4.24	2.12	0.85	1.69	0.42	4.66	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	74.46	1.69	8.04	2.12	2.96	1.69	4.65	0.42	0.85	0.00
stomach, fetal, donor1	10062-101H8	24.56	0.00	1.07	2.14	3.20	0.00	1.07	1.07	0.00	2.14
submaxillary gland, adult	10202-103F4	10.25	0.57	2.28	1.71	0.57	1.71	1.14	0.57	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	7.48	0.42	1.25	0.42	0.00	1.04	0.21	1.25	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	11.38	0.00	1.03	0.00	1.03	0.00	0.00	0.00	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	5.65	0.00	0.00	0.00	1.41	0.71	0.00	0.00	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	30.49	0.69	1.15	3.67	0.46	0.00	0.23	0.00	0.23	0.23
temporal lobe, adult, pool1	10031-101E4	2.88	0.17	0.76	0.51	0.17	0.25	0.42	0.25	0.34	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	7.12	1.42	0.00	1.42	2.14	0.71	2.85	0.71	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	11.87	0.00	0.00	1.76	0.00	0.44	0.88	0.00	0.44	0.88
tenocyte, donor1	11763-123H8	30.37	4.89	9.43	2.44	0.35	1.05	2.44	1.75	1.05	0.35
tenocyte, donor2	11765-123I1	33.95	6.87	9.54	3.05	0.00	1.91	1.91	0.38	1.91	0.38
tenocyte, donor3	11768-123I4	22.61	4.82	3.71	0.37	0.37	2.59	3.71	0.37	1.11	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	91.10	1.70	4.25	2.04	2.38	3.91	0.00	2.55	1.70	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	38.23	1.08	2.16	0.31	3.39	1.54	0.46	0.77	0.31	0.00
teratocarcinoma cell line:PA-1	10807-111A6	132.82	2.48	3.56	2.79	1.70	0.15	1.70	0.46	0.46	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	72.36	6.22	3.55	2.54	0.76	1.27	1.27	1.40	3.81	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	94.54	3.40	2.27	2.27	0.76	2.27	1.89	1.13	3.78	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	203.95	6.22	2.07	1.74	2.40	3.93	3.05	2.62	6.11	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	118.56	8.14	2.61	1.63	6.84	6.19	2.28	5.54	9.77	0.65
testis, adult, pool1	10026-101D8	33.29	1.50	3.87	3.11	0.64	1.07	1.61	0.75	0.75	0.21
testis, adult, pool2	10096-102C6	29.32	1.80	2.71	0.45	0.00	0.45	0.45	0.45	0.45	0.00
thalamus - adult, donor10196	10168-103B6	5.52	0.00	1.10	0.00	0.00	0.00	2.21	0.00	1.10	2.21
thalamus, adult, donor10252	10154-103A1	10.00	0.78	1.09	0.63	0.16	0.63	0.47	0.94	0.63	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	13.86	0.00	3.08	0.00	1.54	0.00	0.00	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	4.78	0.16	2.14	0.82	2.80	0.33	0.00	0.66	0.33	1.65
thalamus, newborn, donor10223	10366-105F6	3.45	0.00	1.73	0.58	1.73	0.00	0.00	0.58	0.00	0.00
throat, adult	10209-103G2	12.73	1.25	1.25	2.25	0.00	0.25	2.25	0.25	0.75	0.75
throat, fetal, donor1	10061-101H7	21.33	1.52	0.91	3.66	0.00	0.91	1.52	0.61	0.30	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	8.74	0.20	1.19	1.59	0.00	0.00	0.00	0.00	0.60	0.00
thymus, adult, pool1	10027-101D9	20.98	1.49	0.70	0.30	0.20	0.60	0.30	0.20	1.39	0.00
thymus, fetal, pool1	10043-101F7	27.95	2.18	1.14	1.66	0.31	1.56	0.62	1.04	0.73	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	62.23	0.80	2.26	1.33	4.12	2.53	0.40	2.13	0.13	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	75.71	2.24	3.63	9.36	8.80	1.54	1.12	1.26	0.56	0.56
thyroid, adult, pool1	10028-101E1	77.54	3.27	6.53	7.09	0.00	0.56	0.75	0.28	1.59	1.21
thyroid, fetal, donor1	10060-101H6	10.55	1.05	1.32	1.58	0.00	0.79	0.53	1.05	0.79	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	0.00	3.08	3.08	0.00	0.00	6.16	0.00	0.00	0.00
tongue, adult	10203-103F5	7.44	1.16	0.70	0.70	0.47	0.47	1.63	0.00	0.47	0.47
tongue, fetal, donor1	10059-101H5	11.03	0.39	0.39	1.97	0.00	0.39	1.18	0.00	0.39	0.39
tonsil, adult, pool1	10047-101G2	26.35	2.50	1.00	2.20	0.00	0.90	1.30	0.70	1.70	0.50
trachea, adult, pool1	10029-101E2	50.72	3.44	2.37	3.84	0.33	1.80	1.23	1.06	1.15	1.55
trachea, fetal, donor1	10058-101H4	16.54	1.54	3.08	1.92	0.38	0.77	1.54	0.00	0.38	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	24.80	0.71	2.83	2.13	2.48	0.00	3.19	0.35	0.00	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	75.08	6.69	2.63	3.24	3.04	0.71	1.42	0.51	1.62	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	138.67	3.92	4.54	5.17	4.07	6.58	1.88	5.01	2.19	1.88
tridermal teratoma cell line:HGRT	10694-109G1	28.54	1.90	1.90	1.90	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	47.23	1.44	2.20	1.27	1.02	0.59	0.42	0.68	0.51	0.17
umbilical cord, fetal, donor1	10057-101H3	14.61	0.00	4.17	2.09	2.09	2.09	2.09	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	48.63	1.54	3.41	2.22	0.00	0.85	1.71	1.19	1.02	0.34
uterus, fetal, donor1	10055-101H1	31.74	0.51	3.58	1.02	0.00	0.51	1.54	0.51	1.02	0.51
vagina, adult	10204-103F6	22.62	1.29	2.58	2.58	0.65	1.29	0.00	1.29	1.94	0.65
vein, adult	10191-103E2	13.59	0.88	0.44	1.75	0.44	1.32	0.66	0.88	0.44	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.27	0.00	0.00	0.00	0.00	0.27	0.00	0.00	0.00	0.00